HRP20160539T1 - Antagonisti trpv4 - Google Patents
Antagonisti trpv4 Download PDFInfo
- Publication number
- HRP20160539T1 HRP20160539T1 HRP20160539TT HRP20160539T HRP20160539T1 HR P20160539 T1 HRP20160539 T1 HR P20160539T1 HR P20160539T T HRP20160539T T HR P20160539TT HR P20160539 T HRP20160539 T HR P20160539T HR P20160539 T1 HRP20160539 T1 HR P20160539T1
- Authority
- HR
- Croatia
- Prior art keywords
- methyl
- azaspiro
- oxa
- oxo
- carbonitrile
- Prior art date
Links
- 101150098315 TRPV4 gene Proteins 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims 24
- 150000001875 compounds Chemical class 0.000 claims 24
- 229910052736 halogen Inorganic materials 0.000 claims 22
- 150000002367 halogens Chemical class 0.000 claims 22
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 22
- 229910052739 hydrogen Inorganic materials 0.000 claims 20
- 239000001257 hydrogen Substances 0.000 claims 20
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 18
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 14
- 125000000217 alkyl group Chemical group 0.000 claims 13
- 125000004432 carbon atom Chemical group C* 0.000 claims 12
- 150000002431 hydrogen Chemical group 0.000 claims 12
- 125000001424 substituent group Chemical group 0.000 claims 12
- AHHWIHXENZJRFG-UHFFFAOYSA-N oxetane Chemical compound C1COC1 AHHWIHXENZJRFG-UHFFFAOYSA-N 0.000 claims 10
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 claims 10
- 125000001412 tetrahydropyranyl group Chemical group 0.000 claims 10
- 229910052799 carbon Inorganic materials 0.000 claims 9
- 229910052757 nitrogen Inorganic materials 0.000 claims 9
- 150000003839 salts Chemical class 0.000 claims 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 8
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 8
- JNCMHMUGTWEVOZ-UHFFFAOYSA-N F[CH]F Chemical compound F[CH]F JNCMHMUGTWEVOZ-UHFFFAOYSA-N 0.000 claims 6
- 108010081348 HRT1 protein Hairy Proteins 0.000 claims 6
- 102100021881 Hairy/enhancer-of-split related with YRPW motif protein 1 Human genes 0.000 claims 6
- MDFFNEOEWAXZRQ-UHFFFAOYSA-N aminyl Chemical compound [NH2] MDFFNEOEWAXZRQ-UHFFFAOYSA-N 0.000 claims 6
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 6
- VUWZPRWSIVNGKG-UHFFFAOYSA-N fluoromethane Chemical compound F[CH2] VUWZPRWSIVNGKG-UHFFFAOYSA-N 0.000 claims 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 6
- 125000003373 pyrazinyl group Chemical group 0.000 claims 6
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 4
- 229910052760 oxygen Inorganic materials 0.000 claims 4
- 239000001301 oxygen Substances 0.000 claims 4
- 125000003386 piperidinyl group Chemical group 0.000 claims 4
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims 4
- AFRKSXHUNUAWNX-DQEYMECFSA-N 3-[[(5s,7s)-3-(1-tert-butylpyrazol-4-yl)-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C1=NN(C(C)(C)C)C=C1N1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 AFRKSXHUNUAWNX-DQEYMECFSA-N 0.000 claims 2
- AKQIVKUXPFPXSB-ZEQRLZLVSA-N 3-[[(5s,7s)-3-(5-ethoxypyrazin-2-yl)-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C1=NC(OCC)=CN=C1N1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 AKQIVKUXPFPXSB-ZEQRLZLVSA-N 0.000 claims 2
- URCMKDJBULWNAI-DQEYMECFSA-N 3-[[(5s,7s)-3-[5-(2-hydroxypropan-2-yl)pyrazin-2-yl]-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C1=NC(C(C)(O)C)=CN=C1N1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 URCMKDJBULWNAI-DQEYMECFSA-N 0.000 claims 2
- 206010007559 Cardiac failure congestive Diseases 0.000 claims 2
- 206010019280 Heart failures Diseases 0.000 claims 2
- 208000019693 Lung disease Diseases 0.000 claims 2
- 206010030113 Oedema Diseases 0.000 claims 2
- 208000002193 Pain Diseases 0.000 claims 2
- 206010069351 acute lung injury Diseases 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000035475 disorder Diseases 0.000 claims 2
- CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical group O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 claims 2
- 208000002551 irritable bowel syndrome Diseases 0.000 claims 2
- 125000003226 pyrazolyl group Chemical group 0.000 claims 2
- KTFUKHNUUGSLQI-RRPNLBNLSA-N 3-[[(5r,7s)-7-methyl-2-oxo-3-[(1-phenyltriazol-4-yl)methyl]-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C([C@]1(CCC[C@@](C1)(CN1C2=CC(=CC=C2N=C1)C#N)C)OC1=O)N1CC(N=N1)=CN1C1=CC=CC=C1 KTFUKHNUUGSLQI-RRPNLBNLSA-N 0.000 claims 1
- UYHVLESCFJXBNJ-BVZFJXPGSA-N 3-[[(5s,7s)-2-oxo-3-(thieno[2,3-b]pyridin-3-ylmethyl)-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C1=NC2=CC=C(C#N)C=C2N1C[C@H](C1)CCC[C@]11OC(=O)N(CC=2C3=CC=CN=C3SC=2)C1 UYHVLESCFJXBNJ-BVZFJXPGSA-N 0.000 claims 1
- BSPGOMROZRVZLE-FNZWTVRRSA-N 3-[[(5s,7s)-2-oxo-3-[(1-phenyltriazol-4-yl)methyl]-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C([C@@]1(OC2=O)C[C@@H](CN3C4=CC(=CC=C4N=C3)C#N)CCC1)N2CC(N=N1)=CN1C1=CC=CC=C1 BSPGOMROZRVZLE-FNZWTVRRSA-N 0.000 claims 1
- FOGCMRDDKOPYNG-OOJDHBDPSA-N 3-[[(5s,7s)-2-oxo-3-[(1-pyridin-2-ylpyrrolidin-3-yl)methyl]-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C([C@@]1(OC2=O)C[C@@H](CN3C4=CC(=CC=C4N=C3)C#N)CCC1)N2CC(C1)CCN1C1=CC=CC=N1 FOGCMRDDKOPYNG-OOJDHBDPSA-N 0.000 claims 1
- NAYBQFHMHDAHOR-DCFHFQCYSA-N 3-[[(5s,7s)-2-oxo-3-[(2-phenyl-1,3-thiazol-4-yl)methyl]-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C([C@@]1(OC2=O)C[C@@H](CN3C4=CC(=CC=C4N=C3)C#N)CCC1)N2CC(N=1)=CSC=1C1=CC=CC=C1 NAYBQFHMHDAHOR-DCFHFQCYSA-N 0.000 claims 1
- RZGVISXWEANAMQ-DCFHFQCYSA-N 3-[[(5s,7s)-2-oxo-3-[(3-phenyl-1,2-oxazol-5-yl)methyl]-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C([C@@]1(OC2=O)C[C@@H](CN3C4=CC(=CC=C4N=C3)C#N)CCC1)N2CC(ON=1)=CC=1C1=CC=CC=C1 RZGVISXWEANAMQ-DCFHFQCYSA-N 0.000 claims 1
- DAOWFDRXVTWDMU-SIBVEZHUSA-N 3-[[(5s,7s)-2-oxo-3-[(3-phenyl-1h-1,2,4-triazol-5-yl)methyl]-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C([C@@]1(OC2=O)C[C@@H](CN3C4=CC(=CC=C4N=C3)C#N)CCC1)N2CC(NN=1)=NC=1C1=CC=CC=C1 DAOWFDRXVTWDMU-SIBVEZHUSA-N 0.000 claims 1
- FTTXJXMCEDWXRE-DCFHFQCYSA-N 3-[[(5s,7s)-2-oxo-3-[(4-phenyl-1,3-thiazol-2-yl)methyl]-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C([C@@]1(OC2=O)C[C@@H](CN3C4=CC(=CC=C4N=C3)C#N)CCC1)N2CC(SC=1)=NC=1C1=CC=CC=C1 FTTXJXMCEDWXRE-DCFHFQCYSA-N 0.000 claims 1
- UAGTZGZDHNEWNI-XLGQKKSSSA-N 3-[[(5s,7s)-2-oxo-3-[(5-phenylpyridin-3-yl)methyl]-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C([C@@]1(OC2=O)C[C@@H](CN3C4=CC(=CC=C4N=C3)C#N)CCC1)N2CC(C=1)=CN=CC=1C1=CC=CC=C1 UAGTZGZDHNEWNI-XLGQKKSSSA-N 0.000 claims 1
- QGDOIUKOAGUFDG-ZTOMLWHTSA-N 3-[[(5s,7s)-2-oxo-3-[(6-phenylpyridin-2-yl)methyl]-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C([C@@]1(OC2=O)C[C@@H](CN3C4=CC(=CC=C4N=C3)C#N)CCC1)N2CC(N=1)=CC=CC=1C1=CC=CC=C1 QGDOIUKOAGUFDG-ZTOMLWHTSA-N 0.000 claims 1
- DKENCZNRDAGBFC-BVZFJXPGSA-N 3-[[(5s,7s)-2-oxo-3-[[1-[2-(trifluoromethyl)pyridin-4-yl]triazol-4-yl]methyl]-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C1=NC(C(F)(F)F)=CC(N2N=NC(CN3C(O[C@@]4(C[C@@H](CN5C6=CC(=CC=C6N=C5)C#N)CCC4)C3)=O)=C2)=C1 DKENCZNRDAGBFC-BVZFJXPGSA-N 0.000 claims 1
- WFOIYBXIAUOWQQ-SIBVEZHUSA-N 3-[[(5s,7s)-2-oxo-3-[[1-[3-(trifluoromethyl)phenyl]triazol-4-yl]methyl]-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound FC(F)(F)C1=CC=CC(N2N=NC(CN3C(O[C@@]4(C[C@@H](CN5C6=CC(=CC=C6N=C5)C#N)CCC4)C3)=O)=C2)=C1 WFOIYBXIAUOWQQ-SIBVEZHUSA-N 0.000 claims 1
- DNMKAIHNGOJDPZ-SIBVEZHUSA-N 3-[[(5s,7s)-2-oxo-3-[[1-[4-(trifluoromethyl)phenyl]triazol-4-yl]methyl]-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C1=CC(C(F)(F)F)=CC=C1N1N=NC(CN2C(O[C@@]3(C[C@@H](CN4C5=CC(=CC=C5N=C4)C#N)CCC3)C2)=O)=C1 DNMKAIHNGOJDPZ-SIBVEZHUSA-N 0.000 claims 1
- UEIQVXPZVSHVMS-BVZFJXPGSA-N 3-[[(5s,7s)-2-oxo-3-[[1-[5-(trifluoromethyl)pyridin-3-yl]triazol-4-yl]methyl]-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound FC(F)(F)C1=CN=CC(N2N=NC(CN3C(O[C@@]4(C[C@@H](CN5C6=CC(=CC=C6N=C5)C#N)CCC4)C3)=O)=C2)=C1 UEIQVXPZVSHVMS-BVZFJXPGSA-N 0.000 claims 1
- QTFSYDKDMPJZLJ-ZEQRLZLVSA-N 3-[[(5s,7s)-3-(1-ethyl-5-methylpyrazol-4-yl)-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound CCN1N=CC(N2C(O[C@@]3(C[C@@](C)(CN4C5=CC(=CC=C5N=C4)C#N)CCC3)C2)=O)=C1C QTFSYDKDMPJZLJ-ZEQRLZLVSA-N 0.000 claims 1
- XEPGYSHKQBIYCM-ZEQRLZLVSA-N 3-[[(5s,7s)-3-(1-tert-butyltriazol-4-yl)-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound N1=NN(C(C)(C)C)C=C1N1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 XEPGYSHKQBIYCM-ZEQRLZLVSA-N 0.000 claims 1
- WKVMXLVJYFNQMV-DQEYMECFSA-N 3-[[(5s,7s)-3-(2,6-dimethoxypyridin-3-yl)-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound COC1=NC(OC)=CC=C1N1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 WKVMXLVJYFNQMV-DQEYMECFSA-N 0.000 claims 1
- KMUQTHRYROLLBY-ZEQRLZLVSA-N 3-[[(5s,7s)-3-(2-ethoxypyrimidin-5-yl)-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C1=NC(OCC)=NC=C1N1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 KMUQTHRYROLLBY-ZEQRLZLVSA-N 0.000 claims 1
- MUAYDAHNXYQCMH-DQEYMECFSA-N 3-[[(5s,7s)-3-(2-methoxy-6-methylpyridin-3-yl)-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound COC1=NC(C)=CC=C1N1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 MUAYDAHNXYQCMH-DQEYMECFSA-N 0.000 claims 1
- BTSAVCILOALRKO-ZEQRLZLVSA-N 3-[[(5s,7s)-3-(2-methoxypyridin-3-yl)-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound COC1=NC=CC=C1N1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 BTSAVCILOALRKO-ZEQRLZLVSA-N 0.000 claims 1
- IDFKVGOOMSLDRI-BVZFJXPGSA-N 3-[[(5s,7s)-3-(2-tert-butylpyrimidin-5-yl)-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C1=NC(C(C)(C)C)=NC=C1N1C(=O)O[C@@]2(C[C@@H](CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 IDFKVGOOMSLDRI-BVZFJXPGSA-N 0.000 claims 1
- QYODVUSWWCYWOU-UIOOFZCWSA-N 3-[[(5s,7s)-3-(2-tert-butylpyrimidin-5-yl)-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C1=NC(C(C)(C)C)=NC=C1N1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 QYODVUSWWCYWOU-UIOOFZCWSA-N 0.000 claims 1
- RJVYNJUTWUJKFM-ZEQRLZLVSA-N 3-[[(5s,7s)-3-(2-tert-butyltriazol-4-yl)-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound CC(C)(C)N1N=CC(N2C(O[C@@]3(C[C@@](C)(CN4C5=CC(=CC=C5N=C4)C#N)CCC3)C2)=O)=N1 RJVYNJUTWUJKFM-ZEQRLZLVSA-N 0.000 claims 1
- RFWARHYIQURAMA-JTSKRJEESA-N 3-[[(5s,7s)-3-(3,4-dimethyl-1,2-oxazol-5-yl)-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound CC1=NOC(N2C(O[C@@]3(C[C@@H](CN4C5=CC(=CC=C5N=C4)C#N)CCC3)C2)=O)=C1C RFWARHYIQURAMA-JTSKRJEESA-N 0.000 claims 1
- UZEJABJVATVUNJ-GOTSBHOMSA-N 3-[[(5s,7s)-3-(3,4-dimethyl-1,2-oxazol-5-yl)-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound CC1=NOC(N2C(O[C@@]3(C[C@@](C)(CN4C5=CC(=CC=C5N=C4)C#N)CCC3)C2)=O)=C1C UZEJABJVATVUNJ-GOTSBHOMSA-N 0.000 claims 1
- WKKWSFCCLQMOTK-ZEQRLZLVSA-N 3-[[(5s,7s)-3-(3,5-dimethylpyrazin-2-yl)-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound CC1=NC(C)=CN=C1N1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 WKKWSFCCLQMOTK-ZEQRLZLVSA-N 0.000 claims 1
- PQINISHGALMEBS-ZEQRLZLVSA-N 3-[[(5s,7s)-3-(3-chloro-5-methylpyridin-2-yl)-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound ClC1=CC(C)=CN=C1N1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 PQINISHGALMEBS-ZEQRLZLVSA-N 0.000 claims 1
- BKKHFQXUEPUWLP-GOTSBHOMSA-N 3-[[(5s,7s)-3-(3-chloropyridin-2-yl)-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C([C@@]1(CCC[C@@](C1)(CN1C2=CC(=CC=C2N=C1)C#N)C)OC1=O)N1C1=NC=CC=C1Cl BKKHFQXUEPUWLP-GOTSBHOMSA-N 0.000 claims 1
- ILSRHLRSLJOTFB-DQEYMECFSA-N 3-[[(5s,7s)-3-(3-cyclobutyl-1,2-oxazol-5-yl)-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C([C@@]1(CCC[C@@](C1)(CN1C2=CC(=CC=C2N=C1)C#N)C)OC1=O)N1C(ON=1)=CC=1C1CCC1 ILSRHLRSLJOTFB-DQEYMECFSA-N 0.000 claims 1
- RJLSCTNIKNNESU-ZEQRLZLVSA-N 3-[[(5s,7s)-3-(3-cyclopropyl-1,2-oxazol-5-yl)-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C([C@@]1(CCC[C@@](C1)(CN1C2=CC(=CC=C2N=C1)C#N)C)OC1=O)N1C(ON=1)=CC=1C1CC1 RJLSCTNIKNNESU-ZEQRLZLVSA-N 0.000 claims 1
- UQOKNVDJMMZPFW-GOTSBHOMSA-N 3-[[(5s,7s)-3-(3-ethyl-1,2-oxazol-5-yl)-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound O1N=C(CC)C=C1N1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 UQOKNVDJMMZPFW-GOTSBHOMSA-N 0.000 claims 1
- PKEIHQONCNVCQG-DQEYMECFSA-N 3-[[(5s,7s)-3-(3-ethylpyridin-2-yl)-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound CCC1=CC=CN=C1N1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 PKEIHQONCNVCQG-DQEYMECFSA-N 0.000 claims 1
- BTTHQJFBAUMHQO-DQEYMECFSA-N 3-[[(5s,7s)-3-(3-methoxy-5-methylpyridin-2-yl)-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound COC1=CC(C)=CN=C1N1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 BTTHQJFBAUMHQO-DQEYMECFSA-N 0.000 claims 1
- PXMRWNDUICPMGO-ZEQRLZLVSA-N 3-[[(5s,7s)-3-(3-methoxypyridin-2-yl)-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound COC1=CC=CN=C1N1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 PXMRWNDUICPMGO-ZEQRLZLVSA-N 0.000 claims 1
- KOSAUXVCQPCSBE-DQEYMECFSA-N 3-[[(5s,7s)-3-(3-tert-butyl-1,2-oxazol-5-yl)-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound O1N=C(C(C)(C)C)C=C1N1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 KOSAUXVCQPCSBE-DQEYMECFSA-N 0.000 claims 1
- PNSHSYAVAGSXBK-DQEYMECFSA-N 3-[[(5s,7s)-3-(3-tert-butyl-4-chloro-1,2-oxazol-5-yl)-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound CC(C)(C)C1=NOC(N2C(O[C@@]3(C[C@@](C)(CN4C5=CC(=CC=C5N=C4)C#N)CCC3)C2)=O)=C1Cl PNSHSYAVAGSXBK-DQEYMECFSA-N 0.000 claims 1
- IRLIJRWUACPNIW-FYSMJZIKSA-N 3-[[(5s,7s)-3-(3-tert-butyl-4-fluoro-1,2-oxazol-5-yl)-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound CC(C)(C)C1=NOC(N2C(O[C@@]3(C[C@@H](CN4C5=CC(=CC=C5N=C4)C#N)CCC3)C2)=O)=C1F IRLIJRWUACPNIW-FYSMJZIKSA-N 0.000 claims 1
- GNHGHFSLUZWPOD-DQEYMECFSA-N 3-[[(5s,7s)-3-(3-tert-butyl-4-fluoro-1,2-oxazol-5-yl)-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound CC(C)(C)C1=NOC(N2C(O[C@@]3(C[C@@](C)(CN4C5=CC(=CC=C5N=C4)C#N)CCC3)C2)=O)=C1F GNHGHFSLUZWPOD-DQEYMECFSA-N 0.000 claims 1
- MNYHTZIFZHVNQE-BVZFJXPGSA-N 3-[[(5s,7s)-3-(3-tert-butyl-4-methyl-1,2-oxazol-5-yl)-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound O1N=C(C(C)(C)C)C(C)=C1N1C(=O)O[C@@]2(C[C@@H](CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 MNYHTZIFZHVNQE-BVZFJXPGSA-N 0.000 claims 1
- KHIDUNPTKCZCLM-UIOOFZCWSA-N 3-[[(5s,7s)-3-(3-tert-butyl-4-methyl-1,2-oxazol-5-yl)-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound O1N=C(C(C)(C)C)C(C)=C1N1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 KHIDUNPTKCZCLM-UIOOFZCWSA-N 0.000 claims 1
- PGWJASHLWFNOMU-XDHUDOTRSA-N 3-[[(5s,7s)-3-(4,6-dimethoxypyridin-3-yl)-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C1=NC(OC)=CC(OC)=C1N1C(=O)O[C@@]2(C[C@@H](CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 PGWJASHLWFNOMU-XDHUDOTRSA-N 0.000 claims 1
- HDJNDWKCQJVNMR-DQEYMECFSA-N 3-[[(5s,7s)-3-(4,6-dimethoxypyridin-3-yl)-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C1=NC(OC)=CC(OC)=C1N1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 HDJNDWKCQJVNMR-DQEYMECFSA-N 0.000 claims 1
- MMNWTNHTOKUOIK-DQEYMECFSA-N 3-[[(5s,7s)-3-(4-bromo-3-tert-butyl-1,2-oxazol-5-yl)-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound CC(C)(C)C1=NOC(N2C(O[C@@]3(C[C@@](C)(CN4C5=CC(=CC=C5N=C4)C#N)CCC3)C2)=O)=C1Br MMNWTNHTOKUOIK-DQEYMECFSA-N 0.000 claims 1
- TTYLJVUXIBQLAY-ZEQRLZLVSA-N 3-[[(5s,7s)-3-(4-methoxypyridin-3-yl)-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound COC1=CC=NC=C1N1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 TTYLJVUXIBQLAY-ZEQRLZLVSA-N 0.000 claims 1
- OMLCUXNUUKPVCQ-DQEYMECFSA-N 3-[[(5s,7s)-3-(4-tert-butyl-1,3-oxazol-2-yl)-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound CC(C)(C)C1=COC(N2C(O[C@@]3(C[C@@](C)(CN4C5=CC(=CC=C5N=C4)C#N)CCC3)C2)=O)=N1 OMLCUXNUUKPVCQ-DQEYMECFSA-N 0.000 claims 1
- VOQLGLLJDSTAPS-GOTSBHOMSA-N 3-[[(5s,7s)-3-(5-chloro-3-fluoropyridin-2-yl)-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C([C@@]1(CCC[C@@](C1)(CN1C2=CC(=CC=C2N=C1)C#N)C)OC1=O)N1C1=NC=C(Cl)C=C1F VOQLGLLJDSTAPS-GOTSBHOMSA-N 0.000 claims 1
- DNUHPRVPHFULLB-ZEQRLZLVSA-N 3-[[(5s,7s)-3-(5-chloro-3-methylpyridin-2-yl)-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound CC1=CC(Cl)=CN=C1N1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 DNUHPRVPHFULLB-ZEQRLZLVSA-N 0.000 claims 1
- ORNUGTMIWCFKMK-ZEQRLZLVSA-N 3-[[(5s,7s)-3-(5-methoxypyridin-2-yl)-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound N1=CC(OC)=CC=C1N1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 ORNUGTMIWCFKMK-ZEQRLZLVSA-N 0.000 claims 1
- SPAGPOAKCTZASZ-DQEYMECFSA-N 3-[[(5s,7s)-3-(5-tert-butyl-1,2-oxazol-3-yl)-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound O1C(C(C)(C)C)=CC(N2C(O[C@@]3(C[C@@](C)(CN4C5=CC(=CC=C5N=C4)C#N)CCC3)C2)=O)=N1 SPAGPOAKCTZASZ-DQEYMECFSA-N 0.000 claims 1
- IDFKXMRIMYXRPU-UIOOFZCWSA-N 3-[[(5s,7s)-3-(5-tert-butyl-2-methylpyrazol-3-yl)-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound CN1N=C(C(C)(C)C)C=C1N1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 IDFKXMRIMYXRPU-UIOOFZCWSA-N 0.000 claims 1
- XLBFXZZCEYCVCY-UIOOFZCWSA-N 3-[[(5s,7s)-3-(5-tert-butylpyrazin-2-yl)-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C1=NC(C(C)(C)C)=CN=C1N1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 XLBFXZZCEYCVCY-UIOOFZCWSA-N 0.000 claims 1
- UMEIYOSGBFNYLK-UIOOFZCWSA-N 3-[[(5s,7s)-3-(5-tert-butylpyrimidin-2-yl)-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound N1=CC(C(C)(C)C)=CN=C1N1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 UMEIYOSGBFNYLK-UIOOFZCWSA-N 0.000 claims 1
- WONHRSLPZPBMKO-HJPURHCSSA-N 3-[[(5s,7s)-3-(6-chloro-4-methoxypyridin-3-yl)-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound COC1=CC(Cl)=NC=C1N1C(=O)O[C@@]2(C[C@@H](CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 WONHRSLPZPBMKO-HJPURHCSSA-N 0.000 claims 1
- QOCJWCNVDNWDOV-ZEQRLZLVSA-N 3-[[(5s,7s)-3-(6-chloro-4-methoxypyridin-3-yl)-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound COC1=CC(Cl)=NC=C1N1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 QOCJWCNVDNWDOV-ZEQRLZLVSA-N 0.000 claims 1
- ZQOKGXLFIDIUNS-SBUREZEXSA-N 3-[[(5s,7s)-3-(6-chloro-4-methylpyridin-3-yl)-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound CC1=CC(Cl)=NC=C1N1C(=O)O[C@@]2(C[C@@H](CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 ZQOKGXLFIDIUNS-SBUREZEXSA-N 0.000 claims 1
- ZYEGXBHPOTXFBP-ZEQRLZLVSA-N 3-[[(5s,7s)-3-(6-chloro-4-methylpyridin-3-yl)-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound CC1=CC(Cl)=NC=C1N1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 ZYEGXBHPOTXFBP-ZEQRLZLVSA-N 0.000 claims 1
- MSGSUWGBZMRXAJ-GOTSBHOMSA-N 3-[[(5s,7s)-3-(6-chloropyridin-3-yl)-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C([C@@]1(CCC[C@@](C1)(CN1C2=CC(=CC=C2N=C1)C#N)C)OC1=O)N1C1=CC=C(Cl)N=C1 MSGSUWGBZMRXAJ-GOTSBHOMSA-N 0.000 claims 1
- HFYRWEVCCGNMHF-SVBPBHIXSA-N 3-[[(5s,7s)-3-(6-cyclopropyl-4-methoxypyridin-3-yl)-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound N=1C=C(N2C(O[C@@]3(C[C@@](C)(CN4C5=CC(=CC=C5N=C4)C#N)CCC3)C2)=O)C(OC)=CC=1C1CC1 HFYRWEVCCGNMHF-SVBPBHIXSA-N 0.000 claims 1
- XGNQJOAXGTWMPJ-DQEYMECFSA-N 3-[[(5s,7s)-3-(6-ethoxy-4-methylpyridazin-3-yl)-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound N1=NC(OCC)=CC(C)=C1N1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 XGNQJOAXGTWMPJ-DQEYMECFSA-N 0.000 claims 1
- NCFFWDVQINNFPS-GKVSMKOHSA-N 3-[[(5s,7s)-3-(6-ethoxy-4-methylpyridin-3-yl)-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]-6-fluorobenzimidazole-5-carbonitrile Chemical compound C1=NC(OCC)=CC(C)=C1N1C(=O)O[C@@]2(C[C@@H](CN3C4=CC(=C(F)C=C4N=C3)C#N)CCC2)C1 NCFFWDVQINNFPS-GKVSMKOHSA-N 0.000 claims 1
- GSTRVOSEYQRBME-DFBJGRDBSA-N 3-[[(5s,7s)-3-(6-ethoxy-4-methylpyridin-3-yl)-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C1=NC(OCC)=CC(C)=C1N1C(=O)O[C@@]2(C[C@@H](CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 GSTRVOSEYQRBME-DFBJGRDBSA-N 0.000 claims 1
- HGERHERQHBJWIY-UIOOFZCWSA-N 3-[[(5s,7s)-3-(6-ethoxy-4-methylpyridin-3-yl)-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C1=NC(OCC)=CC(C)=C1N1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 HGERHERQHBJWIY-UIOOFZCWSA-N 0.000 claims 1
- ADKFYBLTZLMLQY-ZEQRLZLVSA-N 3-[[(5s,7s)-3-(6-ethoxypyridazin-3-yl)-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound N1=NC(OCC)=CC=C1N1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 ADKFYBLTZLMLQY-ZEQRLZLVSA-N 0.000 claims 1
- KNJVKNXKMLRURB-DQEYMECFSA-N 3-[[(5s,7s)-3-(6-ethoxypyridin-3-yl)-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C1=NC(OCC)=CC=C1N1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 KNJVKNXKMLRURB-DQEYMECFSA-N 0.000 claims 1
- PNGJCXNXYWKYLW-UUOWRZLLSA-N 3-[[(5s,7s)-3-(6-methoxy-4-methylpyridin-3-yl)-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C1=NC(OC)=CC(C)=C1N1C(=O)O[C@@]2(C[C@@H](CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 PNGJCXNXYWKYLW-UUOWRZLLSA-N 0.000 claims 1
- INGPNRAWWHYIRY-DQEYMECFSA-N 3-[[(5s,7s)-3-(6-methoxy-4-methylpyridin-3-yl)-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C1=NC(OC)=CC(C)=C1N1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 INGPNRAWWHYIRY-DQEYMECFSA-N 0.000 claims 1
- VHIZXXSODDXVCP-DQEYMECFSA-N 3-[[(5s,7s)-3-(6-methoxy-5-methylpyridin-3-yl)-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C1=C(C)C(OC)=NC=C1N1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 VHIZXXSODDXVCP-DQEYMECFSA-N 0.000 claims 1
- RCIWZIZEVMHRQP-ZEQRLZLVSA-N 3-[[(5s,7s)-3-(6-methoxypyridin-3-yl)-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C1=NC(OC)=CC=C1N1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 RCIWZIZEVMHRQP-ZEQRLZLVSA-N 0.000 claims 1
- HHCYZEMVOFAUON-UIOOFZCWSA-N 3-[[(5s,7s)-3-(6-tert-butylpyridazin-3-yl)-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound N1=NC(C(C)(C)C)=CC=C1N1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 HHCYZEMVOFAUON-UIOOFZCWSA-N 0.000 claims 1
- YRHPCZQTNADCEP-FNZWTVRRSA-N 3-[[(5s,7s)-3-[(1-cyclohexyltriazol-4-yl)methyl]-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C([C@@]1(OC2=O)C[C@@H](CN3C4=CC(=CC=C4N=C3)C#N)CCC1)N2CC(N=N1)=CN1C1CCCCC1 YRHPCZQTNADCEP-FNZWTVRRSA-N 0.000 claims 1
- LKXXGHUZOGZRQH-KMRXNPHXSA-N 3-[[(5s,7s)-3-[(1-methyl-5-phenylpyrazol-3-yl)methyl]-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound CN1N=C(CN2C(O[C@@]3(C[C@@H](CN4C5=CC(=CC=C5N=C4)C#N)CCC3)C2)=O)C=C1C1=CC=CC=C1 LKXXGHUZOGZRQH-KMRXNPHXSA-N 0.000 claims 1
- BFYYHHZINQDGMT-GKVSMKOHSA-N 3-[[(5s,7s)-3-[(3-bromothieno[2,3-b]pyridin-2-yl)methyl]-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound S1C2=NC=CC=C2C(Br)=C1CN1C(=O)O[C@@]2(C[C@@H](CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 BFYYHHZINQDGMT-GKVSMKOHSA-N 0.000 claims 1
- HFGXFDCAGFUJEL-RMBDDCHCSA-N 3-[[(5s,7s)-3-[(3-methyl-1-pyrimidin-2-ylpyrrolidin-3-yl)methyl]-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C1C(C)(CN2C(O[C@@]3(C[C@@H](CN4C5=CC(=CC=C5N=C4)C#N)CCC3)C2)=O)CCN1C1=NC=CC=N1 HFGXFDCAGFUJEL-RMBDDCHCSA-N 0.000 claims 1
- KAQVMVWKPXGSEP-UIOOFZCWSA-N 3-[[(5s,7s)-3-[(4-ethoxypyridin-2-yl)methyl]-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound CCOC1=CC=NC(CN2C(O[C@@]3(C[C@@](C)(CN4C5=CC(=CC=C5N=C4)C#N)CCC3)C2)=O)=C1 KAQVMVWKPXGSEP-UIOOFZCWSA-N 0.000 claims 1
- NWDPWRQAMSGNMT-ZEQRLZLVSA-N 3-[[(5s,7s)-3-[(4-fluoropyridin-2-yl)methyl]-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C([C@@]1(CCC[C@@](C1)(CN1C2=CC(=CC=C2N=C1)C#N)C)OC1=O)N1CC1=CC(F)=CC=N1 NWDPWRQAMSGNMT-ZEQRLZLVSA-N 0.000 claims 1
- PTEOBTYDUZICJQ-QYBDOPJKSA-N 3-[[(5s,7s)-3-[(5-chloro-1-benzothiophen-3-yl)methyl]-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C1=NC2=CC=C(C#N)C=C2N1C[C@H](C1)CCC[C@@]1(OC1=O)CN1CC1=CSC2=CC=C(Cl)C=C21 PTEOBTYDUZICJQ-QYBDOPJKSA-N 0.000 claims 1
- MCDPFHRPNAZHBY-DQEYMECFSA-N 3-[[(5s,7s)-3-[(5-ethoxypyrazin-2-yl)methyl]-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C1=NC(OCC)=CN=C1CN1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 MCDPFHRPNAZHBY-DQEYMECFSA-N 0.000 claims 1
- TURDIGXLIVIFRO-UIOOFZCWSA-N 3-[[(5s,7s)-3-[(5-ethoxypyridin-2-yl)methyl]-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound N1=CC(OCC)=CC=C1CN1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 TURDIGXLIVIFRO-UIOOFZCWSA-N 0.000 claims 1
- QQWOGSKUINIHMG-ZEQRLZLVSA-N 3-[[(5s,7s)-3-[(5-fluoropyridin-2-yl)methyl]-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C([C@@]1(CCC[C@@](C1)(CN1C2=CC(=CC=C2N=C1)C#N)C)OC1=O)N1CC1=CC=C(F)C=N1 QQWOGSKUINIHMG-ZEQRLZLVSA-N 0.000 claims 1
- XWFLVGMRDVJINT-DQEYMECFSA-N 3-[[(5s,7s)-3-[2-(2-hydroxypropan-2-yl)pyrimidin-5-yl]-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C1=NC(C(C)(O)C)=NC=C1N1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 XWFLVGMRDVJINT-DQEYMECFSA-N 0.000 claims 1
- JNXBRKBEYULTBB-MMTVBGGISA-N 3-[[(5s,7s)-3-[2-(3-cyclopentyl-1,2,4-oxadiazol-5-yl)-2-methylpropyl]-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound O([C@@]1(C[C@@H](CN2C3=CC(=CC=C3N=C2)C#N)CCC1)C1)C(=O)N1CC(C)(C)C(ON=1)=NC=1C1CCCC1 JNXBRKBEYULTBB-MMTVBGGISA-N 0.000 claims 1
- VDROKRSZXARPEI-BVZFJXPGSA-N 3-[[(5s,7s)-3-[2-(3-ethyl-1,2,4-oxadiazol-5-yl)-2-methylpropyl]-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound CCC1=NOC(C(C)(C)CN2C(O[C@@]3(C[C@@H](CN4C5=CC(=CC=C5N=C4)C#N)CCC3)C2)=O)=N1 VDROKRSZXARPEI-BVZFJXPGSA-N 0.000 claims 1
- MEMLJXRSCHXKLF-PPHZAIPVSA-N 3-[[(5s,7s)-3-[2-(3-tert-butyl-1,2,4-oxadiazol-5-yl)-2-methylpropyl]-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound CC(C)(C)C1=NOC(C(C)(C)CN2C(O[C@@]3(C[C@@H](CN4C5=CC(=CC=C5N=C4)C#N)CCC3)C2)=O)=N1 MEMLJXRSCHXKLF-PPHZAIPVSA-N 0.000 claims 1
- HKKHJDWVVRHBJL-ZEQRLZLVSA-N 3-[[(5s,7s)-3-[2-(dimethylamino)pyrimidin-5-yl]-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C1=NC(N(C)C)=NC=C1N1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 HKKHJDWVVRHBJL-ZEQRLZLVSA-N 0.000 claims 1
- DLGLTVSFTYBQGD-BTRDEYTCSA-N 3-[[(5s,7s)-3-[2-[3-(1-ethoxyethyl)-1,2,4-oxadiazol-5-yl]-2-methylpropyl]-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound CCOC(C)C1=NOC(C(C)(C)CN2C(O[C@@]3(C[C@@H](CN4C5=CC(=CC=C5N=C4)C#N)CCC3)C2)=O)=N1 DLGLTVSFTYBQGD-BTRDEYTCSA-N 0.000 claims 1
- JKFYAOMKWIYBTD-XSQNJVOOSA-N 3-[[(5s,7s)-3-[2-[3-(1-methoxyethyl)-1,2,4-oxadiazol-5-yl]-2-methylpropyl]-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound COC(C)C1=NOC(C(C)(C)CN2C(O[C@@]3(C[C@@H](CN4C5=CC(=CC=C5N=C4)C#N)CCC3)C2)=O)=N1 JKFYAOMKWIYBTD-XSQNJVOOSA-N 0.000 claims 1
- TWRHLUBNNGBBOU-BVZFJXPGSA-N 3-[[(5s,7s)-3-[2-[3-(methoxymethyl)-1,2,4-oxadiazol-5-yl]-2-methylpropyl]-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound COCC1=NOC(C(C)(C)CN2C(O[C@@]3(C[C@@H](CN4C5=CC(=CC=C5N=C4)C#N)CCC3)C2)=O)=N1 TWRHLUBNNGBBOU-BVZFJXPGSA-N 0.000 claims 1
- SZYBRYJCHHALBT-UUOWRZLLSA-N 3-[[(5s,7s)-3-[2-methyl-2-(3-methyl-1,2,4-oxadiazol-5-yl)propyl]-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound CC1=NOC(C(C)(C)CN2C(O[C@@]3(C[C@@H](CN4C5=CC(=CC=C5N=C4)C#N)CCC3)C2)=O)=N1 SZYBRYJCHHALBT-UUOWRZLLSA-N 0.000 claims 1
- UBZADUKSIXWOAW-LGGPFLRQSA-N 3-[[(5s,7s)-3-[2-methyl-2-(3-phenyl-1,2,4-oxadiazol-5-yl)propyl]-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound O([C@@]1(C[C@@H](CN2C3=CC(=CC=C3N=C2)C#N)CCC1)C1)C(=O)N1CC(C)(C)C(ON=1)=NC=1C1=CC=CC=C1 UBZADUKSIXWOAW-LGGPFLRQSA-N 0.000 claims 1
- WIHJBDBGVRKHMP-SIBVEZHUSA-N 3-[[(5s,7s)-3-[2-methyl-2-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)propyl]-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound CC(C)C1=NOC(C(C)(C)CN2C(O[C@@]3(C[C@@H](CN4C5=CC(=CC=C5N=C4)C#N)CCC3)C2)=O)=N1 WIHJBDBGVRKHMP-SIBVEZHUSA-N 0.000 claims 1
- KODCLHXKXZXIET-PPHZAIPVSA-N 3-[[(5s,7s)-3-[2-methyl-2-(3-pyrimidin-5-yl-1,2,4-oxadiazol-5-yl)propyl]-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound O([C@@]1(C[C@@H](CN2C3=CC(=CC=C3N=C2)C#N)CCC1)C1)C(=O)N1CC(C)(C)C(ON=1)=NC=1C1=CN=CN=C1 KODCLHXKXZXIET-PPHZAIPVSA-N 0.000 claims 1
- PDZSNKDNEDXRBK-LGGPFLRQSA-N 3-[[(5s,7s)-3-[2-methyl-2-(5-phenyl-1,3,4-oxadiazol-2-yl)propyl]-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound O([C@@]1(C[C@@H](CN2C3=CC(=CC=C3N=C2)C#N)CCC1)C1)C(=O)N1CC(C)(C)C(O1)=NN=C1C1=CC=CC=C1 PDZSNKDNEDXRBK-LGGPFLRQSA-N 0.000 claims 1
- ZIJDHCDFIWYFMB-DCFHFQCYSA-N 3-[[(5s,7s)-3-[2-methyl-2-[3-(2-methylpropyl)-1,2,4-oxadiazol-5-yl]propyl]-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound CC(C)CC1=NOC(C(C)(C)CN2C(O[C@@]3(C[C@@H](CN4C5=CC(=CC=C5N=C4)C#N)CCC3)C2)=O)=N1 ZIJDHCDFIWYFMB-DCFHFQCYSA-N 0.000 claims 1
- PADMHWYWQSGFJM-MMTVBGGISA-N 3-[[(5s,7s)-3-[2-methyl-2-[3-(oxan-4-yl)-1,2,4-oxadiazol-5-yl]propyl]-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound O([C@@]1(C[C@@H](CN2C3=CC(=CC=C3N=C2)C#N)CCC1)C1)C(=O)N1CC(C)(C)C(ON=1)=NC=1C1CCOCC1 PADMHWYWQSGFJM-MMTVBGGISA-N 0.000 claims 1
- TXAJVDHOJTZASH-DCFHFQCYSA-N 3-[[(5s,7s)-3-[2-methyl-2-[3-(propan-2-yloxymethyl)-1,2,4-oxadiazol-5-yl]propyl]-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound CC(C)OCC1=NOC(C(C)(C)CN2C(O[C@@]3(C[C@@H](CN4C5=CC(=CC=C5N=C4)C#N)CCC3)C2)=O)=N1 TXAJVDHOJTZASH-DCFHFQCYSA-N 0.000 claims 1
- FHQZCYSNHHVYJQ-HJPURHCSSA-N 3-[[(5s,7s)-3-[2-methyl-2-[3-(trifluoromethyl)-1,2,4-oxadiazol-5-yl]propyl]-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound O([C@@]1(C[C@@H](CN2C3=CC(=CC=C3N=C2)C#N)CCC1)C1)C(=O)N1CC(C)(C)C1=NC(C(F)(F)F)=NO1 FHQZCYSNHHVYJQ-HJPURHCSSA-N 0.000 claims 1
- RTIARAJDTFZQDX-GMAHTHKFSA-N 3-[[(5s,7s)-3-[3-(1,1-difluoroethyl)-1,2-oxazol-5-yl]-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound O1N=C(C(F)(F)C)C=C1N1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 RTIARAJDTFZQDX-GMAHTHKFSA-N 0.000 claims 1
- XEORZBWBTJYHNX-ZCYQVOJMSA-N 3-[[(5s,7s)-3-[3-(1-cyanocyclopropyl)-1,2-oxazol-5-yl]-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C([C@@]1(CCC[C@@](C1)(CN1C2=CC(=CC=C2N=C1)C#N)C)OC1=O)N1C(ON=1)=CC=1C1(C#N)CC1 XEORZBWBTJYHNX-ZCYQVOJMSA-N 0.000 claims 1
- ROHFLSCJISFEEX-DQEYMECFSA-N 3-[[(5s,7s)-3-[3-(1-hydroxy-2-methylpropan-2-yl)-1,2-oxazol-5-yl]-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound O1N=C(C(C)(CO)C)C=C1N1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 ROHFLSCJISFEEX-DQEYMECFSA-N 0.000 claims 1
- PLPLZKXXPZXNTR-DQEYMECFSA-N 3-[[(5s,7s)-3-[3-(2-cyanopropan-2-yl)-1,2-oxazol-5-yl]-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound O1N=C(C(C)(C#N)C)C=C1N1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 PLPLZKXXPZXNTR-DQEYMECFSA-N 0.000 claims 1
- YTRXYMJSVISDER-ZEQRLZLVSA-N 3-[[(5s,7s)-3-[3-(2-fluoropropan-2-yl)-1,2-oxazol-5-yl]-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound O1N=C(C(C)(F)C)C=C1N1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 YTRXYMJSVISDER-ZEQRLZLVSA-N 0.000 claims 1
- HVZIKTHMARKVBF-AOMKIAJQSA-N 3-[[(5s,7s)-3-[3-methyl-5-(trifluoromethyl)pyrazin-2-yl]-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound CC1=NC(C(F)(F)F)=CN=C1N1C(=O)O[C@@]2(C[C@@H](CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 HVZIKTHMARKVBF-AOMKIAJQSA-N 0.000 claims 1
- HOJRGZODESOWTN-DQEYMECFSA-N 3-[[(5s,7s)-3-[4-chloro-3-(2-cyanopropan-2-yl)-1,2-oxazol-5-yl]-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound N#CC(C)(C)C1=NOC(N2C(O[C@@]3(C[C@@](C)(CN4C5=CC(=CC=C5N=C4)C#N)CCC3)C2)=O)=C1Cl HOJRGZODESOWTN-DQEYMECFSA-N 0.000 claims 1
- PFHTWXNNBIZBMG-AOMKIAJQSA-N 3-[[(5s,7s)-3-[4-methyl-2-(trifluoromethyl)pyrimidin-5-yl]-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound CC1=NC(C(F)(F)F)=NC=C1N1C(=O)O[C@@]2(C[C@@H](CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 PFHTWXNNBIZBMG-AOMKIAJQSA-N 0.000 claims 1
- QXYGHNOMUADQSG-UIOOFZCWSA-N 3-[[(5s,7s)-3-[5-(1-hydroxy-2-methylpropan-2-yl)pyrazin-2-yl]-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C1=NC(C(C)(CO)C)=CN=C1N1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 QXYGHNOMUADQSG-UIOOFZCWSA-N 0.000 claims 1
- XGQARGJNRMNFJU-UIOOFZCWSA-N 3-[[(5s,7s)-3-[5-(2-hydroxypropan-2-yl)pyridin-2-yl]-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound N1=CC(C(C)(O)C)=CC=C1N1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 XGQARGJNRMNFJU-UIOOFZCWSA-N 0.000 claims 1
- UTDBSALATVTYNQ-UIOOFZCWSA-N 3-[[(5s,7s)-3-[5-(2-methoxypropan-2-yl)pyrazin-2-yl]-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C1=NC(C(C)(C)OC)=CN=C1N1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 UTDBSALATVTYNQ-UIOOFZCWSA-N 0.000 claims 1
- HHSPKJCCTPBXRL-ZEQRLZLVSA-N 3-[[(5s,7s)-3-[5-(dimethylamino)pyrazin-2-yl]-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C1=NC(N(C)C)=CN=C1N1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 HHSPKJCCTPBXRL-ZEQRLZLVSA-N 0.000 claims 1
- MRNAPMHFBPYVFY-NSOVKSMOSA-N 3-[[(5s,7s)-3-[5-[2-(2-methoxyethoxy)propan-2-yl]pyrazin-2-yl]-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C1=NC(C(C)(C)OCCOC)=CN=C1N1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 MRNAPMHFBPYVFY-NSOVKSMOSA-N 0.000 claims 1
- ANWXFJFNERCHLR-SVBPBHIXSA-N 3-[[(5s,7s)-3-[6-(2-cyanopropan-2-yl)pyridin-3-yl]-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C1=NC(C(C)(C#N)C)=CC=C1N1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 ANWXFJFNERCHLR-SVBPBHIXSA-N 0.000 claims 1
- XQEVEKGWVTZESQ-SVBPBHIXSA-N 3-[[(5s,7s)-3-[6-(2-methoxypropan-2-yl)pyridin-3-yl]-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C1=NC(C(C)(C)OC)=CC=C1N1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 XQEVEKGWVTZESQ-SVBPBHIXSA-N 0.000 claims 1
- MUDAQAGUGSNTEW-VMPREFPWSA-N 3-[[(5s,7s)-3-[6-(5-fluoropyridin-2-yl)-4-methylpyridin-3-yl]-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound N=1C=C(N2C(O[C@@]3(C[C@@](C)(CN4C5=CC(=CC=C5N=C4)C#N)CCC3)C2)=O)C(C)=CC=1C1=CC=C(F)C=N1 MUDAQAGUGSNTEW-VMPREFPWSA-N 0.000 claims 1
- UMFMYMJLDOHSCL-DQEYMECFSA-N 3-[[(5s,7s)-3-[6-(dimethylamino)pyridin-3-yl]-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C1=NC(N(C)C)=CC=C1N1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 UMFMYMJLDOHSCL-DQEYMECFSA-N 0.000 claims 1
- IQGKTSDYEAKCJR-QYBDOPJKSA-N 3-[[(5s,7s)-3-[[1-(3,5-difluorophenyl)triazol-4-yl]methyl]-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound FC1=CC(F)=CC(N2N=NC(CN3C(O[C@@]4(C[C@@H](CN5C6=CC(=CC=C6N=C5)C#N)CCC4)C3)=O)=C2)=C1 IQGKTSDYEAKCJR-QYBDOPJKSA-N 0.000 claims 1
- VEQUFJQVNXQSSC-PPHZAIPVSA-N 3-[[(5s,7s)-3-[[1-(3-chloro-5-cyanophenyl)triazol-4-yl]methyl]-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound ClC1=CC(C#N)=CC(N2N=NC(CN3C(O[C@@]4(C[C@@H](CN5C6=CC(=CC=C6N=C5)C#N)CCC4)C3)=O)=C2)=C1 VEQUFJQVNXQSSC-PPHZAIPVSA-N 0.000 claims 1
- KZSACMUDZZDILE-SIBVEZHUSA-N 3-[[(5s,7s)-3-[[1-(3-chlorophenyl)triazol-4-yl]methyl]-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound ClC1=CC=CC(N2N=NC(CN3C(O[C@@]4(C[C@@H](CN5C6=CC(=CC=C6N=C5)C#N)CCC4)C3)=O)=C2)=C1 KZSACMUDZZDILE-SIBVEZHUSA-N 0.000 claims 1
- QJCSPJUDQHUBGO-PPHZAIPVSA-N 3-[[(5s,7s)-3-[[1-(3-cyano-5-fluorophenyl)triazol-4-yl]methyl]-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound FC1=CC(C#N)=CC(N2N=NC(CN3C(O[C@@]4(C[C@@H](CN5C6=CC(=CC=C6N=C5)C#N)CCC4)C3)=O)=C2)=C1 QJCSPJUDQHUBGO-PPHZAIPVSA-N 0.000 claims 1
- HCTYFDLOVKVHSK-IDISGSTGSA-N 3-[[(5s,7s)-3-[[1-(3-cyanophenyl)triazol-4-yl]methyl]-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C([C@@]1(OC2=O)C[C@@H](CN3C4=CC(=CC=C4N=C3)C#N)CCC1)N2CC(N=N1)=CN1C1=CC=CC(C#N)=C1 HCTYFDLOVKVHSK-IDISGSTGSA-N 0.000 claims 1
- WMUOEIURPANJRT-SIBVEZHUSA-N 3-[[(5s,7s)-3-[[1-(3-fluorophenyl)triazol-4-yl]methyl]-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound FC1=CC=CC(N2N=NC(CN3C(O[C@@]4(C[C@@H](CN5C6=CC(=CC=C6N=C5)C#N)CCC4)C3)=O)=C2)=C1 WMUOEIURPANJRT-SIBVEZHUSA-N 0.000 claims 1
- QYXGIAMYDNJMIA-DCFHFQCYSA-N 3-[[(5s,7s)-3-[[1-(3-methoxyphenyl)triazol-4-yl]methyl]-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound COC1=CC=CC(N2N=NC(CN3C(O[C@@]4(C[C@@H](CN5C6=CC(=CC=C6N=C5)C#N)CCC4)C3)=O)=C2)=C1 QYXGIAMYDNJMIA-DCFHFQCYSA-N 0.000 claims 1
- CQKXQKLAULLWND-IDISGSTGSA-N 3-[[(5s,7s)-3-[[1-(3-methylphenyl)triazol-4-yl]methyl]-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound CC1=CC=CC(N2N=NC(CN3C(O[C@@]4(C[C@@H](CN5C6=CC(=CC=C6N=C5)C#N)CCC4)C3)=O)=C2)=C1 CQKXQKLAULLWND-IDISGSTGSA-N 0.000 claims 1
- MGGJIASIQQJNEY-SIBVEZHUSA-N 3-[[(5s,7s)-3-[[1-(4-chlorophenyl)triazol-4-yl]methyl]-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C1=CC(Cl)=CC=C1N1N=NC(CN2C(O[C@@]3(C[C@@H](CN4C5=CC(=CC=C5N=C4)C#N)CCC3)C2)=O)=C1 MGGJIASIQQJNEY-SIBVEZHUSA-N 0.000 claims 1
- MVXFGELRKKKCLN-IDISGSTGSA-N 3-[[(5s,7s)-3-[[1-(4-cyanophenyl)triazol-4-yl]methyl]-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C([C@@]1(OC2=O)C[C@@H](CN3C4=CC(=CC=C4N=C3)C#N)CCC1)N2CC(N=N1)=CN1C1=CC=C(C#N)C=C1 MVXFGELRKKKCLN-IDISGSTGSA-N 0.000 claims 1
- GDXHRDONGTVEQX-IDISGSTGSA-N 3-[[(5s,7s)-3-[[1-(4-methylphenyl)triazol-4-yl]methyl]-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C1=CC(C)=CC=C1N1N=NC(CN2C(O[C@@]3(C[C@@H](CN4C5=CC(=CC=C5N=C4)C#N)CCC3)C2)=O)=C1 GDXHRDONGTVEQX-IDISGSTGSA-N 0.000 claims 1
- URERBFWHKBXPGE-BVZFJXPGSA-N 3-[[(5s,7s)-3-[[1-(5-chloropyridin-3-yl)triazol-4-yl]methyl]-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound ClC1=CN=CC(N2N=NC(CN3C(O[C@@]4(C[C@@H](CN5C6=CC(=CC=C6N=C5)C#N)CCC4)C3)=O)=C2)=C1 URERBFWHKBXPGE-BVZFJXPGSA-N 0.000 claims 1
- UCZRIPDVPVVMCX-PPHZAIPVSA-N 3-[[(5s,7s)-3-[[1-[4-cyano-3-(trifluoromethyl)phenyl]triazol-4-yl]methyl]-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C1=C(C#N)C(C(F)(F)F)=CC(N2N=NC(CN3C(O[C@@]4(C[C@@H](CN5C6=CC(=CC=C6N=C5)C#N)CCC4)C3)=O)=C2)=C1 UCZRIPDVPVVMCX-PPHZAIPVSA-N 0.000 claims 1
- AVGAOELALDXVRL-PPHZAIPVSA-N 3-[[(5s,7s)-3-[[3-(4-chlorophenyl)-1,2-oxazol-5-yl]methyl]-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C1=CC(Cl)=CC=C1C1=NOC(CN2C(O[C@@]3(C[C@@H](CN4C5=CC(=CC=C5N=C4)C#N)CCC3)C2)=O)=C1 AVGAOELALDXVRL-PPHZAIPVSA-N 0.000 claims 1
- STLHKAFHEAPIBY-LGGPFLRQSA-N 3-[[(5s,7s)-3-[[4-(4-methoxy-3-methylphenyl)-1,3-thiazol-2-yl]methyl]-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C1=C(C)C(OC)=CC=C1C1=CSC(CN2C(O[C@@]3(C[C@@H](CN4C5=CC(=CC=C5N=C4)C#N)CCC3)C2)=O)=N1 STLHKAFHEAPIBY-LGGPFLRQSA-N 0.000 claims 1
- JFDKAWITNHVOIK-SVBPBHIXSA-N 3-[[(5s,7s)-7-methyl-2-oxo-3-(3-phenyl-1,2-oxazol-5-yl)-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C([C@@]1(CCC[C@@](C1)(CN1C2=CC(=CC=C2N=C1)C#N)C)OC1=O)N1C(ON=1)=CC=1C1=CC=CC=C1 JFDKAWITNHVOIK-SVBPBHIXSA-N 0.000 claims 1
- BGWFPGSXVMEKMM-ZEQRLZLVSA-N 3-[[(5s,7s)-7-methyl-2-oxo-3-(3-prop-1-en-2-yl-1,2-oxazol-5-yl)-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound O1N=C(C(=C)C)C=C1N1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 BGWFPGSXVMEKMM-ZEQRLZLVSA-N 0.000 claims 1
- QMDFYZGWKSODQN-ZEQRLZLVSA-N 3-[[(5s,7s)-7-methyl-2-oxo-3-(3-propan-2-yl-1,2-oxazol-5-yl)-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound O1N=C(C(C)C)C=C1N1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 QMDFYZGWKSODQN-ZEQRLZLVSA-N 0.000 claims 1
- NULTZQPYYBAWCL-ZEQRLZLVSA-N 3-[[(5s,7s)-7-methyl-2-oxo-3-(pyridin-2-ylmethyl)-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C([C@@]1(CCC[C@@](C1)(CN1C2=CC(=CC=C2N=C1)C#N)C)OC1=O)N1CC1=CC=CC=N1 NULTZQPYYBAWCL-ZEQRLZLVSA-N 0.000 claims 1
- KTFUKHNUUGSLQI-SVBPBHIXSA-N 3-[[(5s,7s)-7-methyl-2-oxo-3-[(1-phenyltriazol-4-yl)methyl]-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C([C@@]1(CCC[C@@](C1)(CN1C2=CC(=CC=C2N=C1)C#N)C)OC1=O)N1CC(N=N1)=CN1C1=CC=CC=C1 KTFUKHNUUGSLQI-SVBPBHIXSA-N 0.000 claims 1
- UFOCGGVVMXEIIA-ZEQRLZLVSA-N 3-[[(5s,7s)-7-methyl-2-oxo-3-[(1-propan-2-yltriazol-4-yl)methyl]-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound N1=NN(C(C)C)C=C1CN1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 UFOCGGVVMXEIIA-ZEQRLZLVSA-N 0.000 claims 1
- RESSSLMKEVWIMK-VXKWHMMOSA-N 3-[[(5s,7s)-7-methyl-2-oxo-3-[2-(trifluoromethyl)pyrimidin-5-yl]-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C([C@@]1(CCC[C@@](C1)(CN1C2=CC(=CC=C2N=C1)C#N)C)OC1=O)N1C1=CN=C(C(F)(F)F)N=C1 RESSSLMKEVWIMK-VXKWHMMOSA-N 0.000 claims 1
- YQVMFZOOLCNJTQ-SFTDATJTSA-N 3-[[(5s,7s)-7-methyl-2-oxo-3-[3-(trifluoromethyl)-1,2-oxazol-5-yl]-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C([C@@]1(CCC[C@@](C1)(CN1C2=CC(=CC=C2N=C1)C#N)C)OC1=O)N1C1=CC(C(F)(F)F)=NO1 YQVMFZOOLCNJTQ-SFTDATJTSA-N 0.000 claims 1
- IYCABOBBUBJNJP-GOTSBHOMSA-N 3-[[(5s,7s)-7-methyl-2-oxo-3-[3-(trifluoromethyl)pyridin-2-yl]-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C([C@@]1(CCC[C@@](C1)(CN1C2=CC(=CC=C2N=C1)C#N)C)OC1=O)N1C1=NC=CC=C1C(F)(F)F IYCABOBBUBJNJP-GOTSBHOMSA-N 0.000 claims 1
- DOSUZTMWMNSIEQ-GOTSBHOMSA-N 3-[[(5s,7s)-7-methyl-2-oxo-3-[4-(trifluoromethyl)pyridin-3-yl]-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C([C@@]1(CCC[C@@](C1)(CN1C2=CC(=CC=C2N=C1)C#N)C)OC1=O)N1C1=CN=CC=C1C(F)(F)F DOSUZTMWMNSIEQ-GOTSBHOMSA-N 0.000 claims 1
- XTDSFINOJHBFNV-VXKWHMMOSA-N 3-[[(5s,7s)-7-methyl-2-oxo-3-[5-(trifluoromethyl)pyrazin-2-yl]-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C([C@@]1(CCC[C@@](C1)(CN1C2=CC(=CC=C2N=C1)C#N)C)OC1=O)N1C1=CN=C(C(F)(F)F)C=N1 XTDSFINOJHBFNV-VXKWHMMOSA-N 0.000 claims 1
- ASYSUKWBKPTZDB-GOTSBHOMSA-N 3-[[(5s,7s)-7-methyl-2-oxo-3-[5-(trifluoromethyl)pyridin-2-yl]-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C([C@@]1(CCC[C@@](C1)(CN1C2=CC(=CC=C2N=C1)C#N)C)OC1=O)N1C1=CC=C(C(F)(F)F)C=N1 ASYSUKWBKPTZDB-GOTSBHOMSA-N 0.000 claims 1
- RXQHVAVNIPUTPP-VXKWHMMOSA-N 3-[[(5s,7s)-7-methyl-2-oxo-3-[5-(trifluoromethyl)pyrimidin-2-yl]-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C([C@@]1(CCC[C@@](C1)(CN1C2=CC(=CC=C2N=C1)C#N)C)OC1=O)N1C1=NC=C(C(F)(F)F)C=N1 RXQHVAVNIPUTPP-VXKWHMMOSA-N 0.000 claims 1
- JTYZHTYUGPXOFR-GOTSBHOMSA-N 3-[[(5s,7s)-7-methyl-2-oxo-3-[6-(trifluoromethyl)pyridin-3-yl]-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C([C@@]1(CCC[C@@](C1)(CN1C2=CC(=CC=C2N=C1)C#N)C)OC1=O)N1C1=CC=C(C(F)(F)F)N=C1 JTYZHTYUGPXOFR-GOTSBHOMSA-N 0.000 claims 1
- SDYNLZSJQOFZJY-NSOVKSMOSA-N 3-[[(5s,7s)-7-methyl-3-(4-methyl-6-morpholin-4-ylpyridin-3-yl)-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound N=1C=C(N2C(O[C@@]3(C[C@@](C)(CN4C5=CC(=CC=C5N=C4)C#N)CCC3)C2)=O)C(C)=CC=1N1CCOCC1 SDYNLZSJQOFZJY-NSOVKSMOSA-N 0.000 claims 1
- SMPVEZOTQYFLBT-ZEQRLZLVSA-N 3-[[(5s,7s)-7-methyl-3-(4-methylpyridin-3-yl)-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound CC1=CC=NC=C1N1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 SMPVEZOTQYFLBT-ZEQRLZLVSA-N 0.000 claims 1
- AJACEJKXEVQAAE-GOTSBHOMSA-N 3-[[(5s,7s)-7-methyl-3-(5-methylpyrazin-2-yl)-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C1=NC(C)=CN=C1N1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 AJACEJKXEVQAAE-GOTSBHOMSA-N 0.000 claims 1
- FBTIVMZAGQIVQP-ZEQRLZLVSA-N 3-[[(5s,7s)-7-methyl-3-(5-methylpyridin-2-yl)-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound N1=CC(C)=CC=C1N1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 FBTIVMZAGQIVQP-ZEQRLZLVSA-N 0.000 claims 1
- BWTLVOXPCDNKOT-DQEYMECFSA-N 3-[[(5s,7s)-7-methyl-3-[3-(1-methylpyrazol-3-yl)-1,2-oxazol-5-yl]-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound CN1C=CC(C2=NOC(=C2)N2C(O[C@@]3(C[C@@](C)(CN4C5=CC(=CC=C5N=C4)C#N)CCC3)C2)=O)=N1 BWTLVOXPCDNKOT-DQEYMECFSA-N 0.000 claims 1
- AZBQCBPFJAYZSQ-DQEYMECFSA-N 3-[[(5s,7s)-7-methyl-3-[3-(2-methylpropyl)-1,2-oxazol-5-yl]-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound O1N=C(CC(C)C)C=C1N1C(=O)O[C@@]2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 AZBQCBPFJAYZSQ-DQEYMECFSA-N 0.000 claims 1
- DRYQLZOXIAJDGV-NSOVKSMOSA-N 3-[[(5s,7s)-7-methyl-3-[[4-(1-methylpyrazol-4-yl)pyridin-2-yl]methyl]-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C1=NN(C)C=C1C1=CC=NC(CN2C(O[C@@]3(C[C@@](C)(CN4C5=CC(=CC=C5N=C4)C#N)CCC3)C2)=O)=C1 DRYQLZOXIAJDGV-NSOVKSMOSA-N 0.000 claims 1
- WZGFEDBQRDKQFK-NSOVKSMOSA-N 3-[[(5s,7s)-7-methyl-3-[[6-(1-methylpyrazol-4-yl)pyridin-2-yl]methyl]-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C1=NN(C)C=C1C1=CC=CC(CN2C(O[C@@]3(C[C@@](C)(CN4C5=CC(=CC=C5N=C4)C#N)CCC3)C2)=O)=N1 WZGFEDBQRDKQFK-NSOVKSMOSA-N 0.000 claims 1
- TURZMLRKHPVQOJ-NQCNTLBGSA-N 3-[[(7s)-3-(3,5-dichloropyridin-2-yl)-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C([C@@](C1)(CN2C3=CC(=CC=C3N=C2)C#N)C)CCC1(OC1=O)CN1C1=NC=C(Cl)C=C1Cl TURZMLRKHPVQOJ-NQCNTLBGSA-N 0.000 claims 1
- DUEXHLAZZMWMNZ-NQCNTLBGSA-N 3-[[(7s)-3-(5-methoxypyrazin-2-yl)-7-methyl-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C1=NC(OC)=CN=C1N1C(=O)OC2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 DUEXHLAZZMWMNZ-NQCNTLBGSA-N 0.000 claims 1
- HONJYVRVDOBGME-UXMRNZNESA-N 3-[[(7s)-7-methyl-3-(6-methylpyridin-3-yl)-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C1=NC(C)=CC=C1N1C(=O)OC2(C[C@@](C)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 HONJYVRVDOBGME-UXMRNZNESA-N 0.000 claims 1
- YRGWAIQFKIIQCB-UHFFFAOYSA-N 3-[[3-(1-benzothiophen-3-ylmethyl)-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C1=NC2=CC=C(C#N)C=C2N1CC(C1)CCCC11OC(=O)N(CC=2C3=CC=CC=C3SC=2)C1 YRGWAIQFKIIQCB-UHFFFAOYSA-N 0.000 claims 1
- VJCPTFGQFDRGBM-UHFFFAOYSA-N 3-[[3-[(5-chloro-1-benzothiophen-3-yl)methyl]-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]-2-(trifluoromethyl)benzimidazole-5-carbonitrile Chemical compound C1=C(Cl)C=C2C(CN3CC4(CCCC(C4)CN4C5=CC(=CC=C5N=C4C(F)(F)F)C#N)OC3=O)=CSC2=C1 VJCPTFGQFDRGBM-UHFFFAOYSA-N 0.000 claims 1
- PTEOBTYDUZICJQ-UHFFFAOYSA-N 3-[[3-[(5-chloro-1-benzothiophen-3-yl)methyl]-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C1=NC2=CC=C(C#N)C=C2N1CC(C1)CCCC1(OC1=O)CN1CC1=CSC2=CC=C(Cl)C=C21 PTEOBTYDUZICJQ-UHFFFAOYSA-N 0.000 claims 1
- MFGZHSGSQDOYIK-UHFFFAOYSA-N 3-[[7-(hydroxymethyl)-3-(6-methoxy-4-methylpyridin-3-yl)-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C1=NC(OC)=CC(C)=C1N1C(=O)OC2(CC(CO)(CN3C4=CC(=CC=C4N=C3)C#N)CCC2)C1 MFGZHSGSQDOYIK-UHFFFAOYSA-N 0.000 claims 1
- RALMIIKBIJWFJI-BGOLNKOXSA-N 7-chloro-3-[[(5s,7s)-2-oxo-3-[[4-(3-phenyl-1,2,4-oxadiazol-5-yl)oxan-4-yl]methyl]-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C([C@@]1(CCC[C@@H](C1)CN1C=2C=C(C=C(C=2N=C1)Cl)C#N)OC1=O)N1CC1(C=2ON=C(N=2)C=2C=CC=CC=2)CCOCC1 RALMIIKBIJWFJI-BGOLNKOXSA-N 0.000 claims 1
- YRGLMFFHRJCALL-SLQAJWMNSA-N 7-chloro-3-[[(5s,7s)-3-[2-methyl-2-(3-phenyl-1,2,4-oxadiazol-5-yl)propyl]-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound O([C@@]1(C[C@@H](CN2C3=CC(=CC(Cl)=C3N=C2)C#N)CCC1)C1)C(=O)N1CC(C)(C)C(ON=1)=NC=1C1=CC=CC=C1 YRGLMFFHRJCALL-SLQAJWMNSA-N 0.000 claims 1
- KZWYQAKGFGFBQA-WRGVRERRSA-N 7-chloro-3-[[(5s,7s)-3-[[4-(3-cyclopentyl-1,2,4-oxadiazol-5-yl)oxan-4-yl]methyl]-2-oxo-1-oxa-3-azaspiro[4.5]decan-7-yl]methyl]benzimidazole-5-carbonitrile Chemical compound C([C@@]1(CCC[C@@H](C1)CN1C=2C=C(C=C(C=2N=C1)Cl)C#N)OC1=O)N1CC1(C=2ON=C(N=2)C2CCCC2)CCOCC1 KZWYQAKGFGFBQA-WRGVRERRSA-N 0.000 claims 1
- 201000001320 Atherosclerosis Diseases 0.000 claims 1
- 208000024172 Cardiovascular disease Diseases 0.000 claims 1
- 208000015943 Coeliac disease Diseases 0.000 claims 1
- 206010010774 Constipation Diseases 0.000 claims 1
- 208000011231 Crohn disease Diseases 0.000 claims 1
- 206010012735 Diarrhoea Diseases 0.000 claims 1
- 206010016807 Fluid retention Diseases 0.000 claims 1
- 206010058061 Gastrointestinal oedema Diseases 0.000 claims 1
- 208000035202 High altitude pulmonary edema Diseases 0.000 claims 1
- 206010020772 Hypertension Diseases 0.000 claims 1
- 206010020853 Hypertonic bladder Diseases 0.000 claims 1
- 206010021639 Incontinence Diseases 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- 201000010538 Lactose Intolerance Diseases 0.000 claims 1
- 208000007101 Muscle Cramp Diseases 0.000 claims 1
- 208000009722 Overactive Urinary Bladder Diseases 0.000 claims 1
- 206010062237 Renal impairment Diseases 0.000 claims 1
- 206010040047 Sepsis Diseases 0.000 claims 1
- 208000005392 Spasm Diseases 0.000 claims 1
- 208000010285 Ventilator-Induced Lung Injury Diseases 0.000 claims 1
- 230000003187 abdominal effect Effects 0.000 claims 1
- 230000001154 acute effect Effects 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 210000000988 bone and bone Anatomy 0.000 claims 1
- 230000001684 chronic effect Effects 0.000 claims 1
- 206010009887 colitis Diseases 0.000 claims 1
- 230000004064 dysfunction Effects 0.000 claims 1
- 230000006870 function Effects 0.000 claims 1
- 230000035874 hyperreactivity Effects 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 230000003871 intestinal function Effects 0.000 claims 1
- 210000000936 intestine Anatomy 0.000 claims 1
- 230000001788 irregular Effects 0.000 claims 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 230000005977 kidney dysfunction Effects 0.000 claims 1
- 125000002757 morpholinyl group Chemical group 0.000 claims 1
- 208000005264 motor neuron disease Diseases 0.000 claims 1
- 230000000414 obstructive effect Effects 0.000 claims 1
- 201000008482 osteoarthritis Diseases 0.000 claims 1
- 208000020629 overactive bladder Diseases 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 230000002980 postoperative effect Effects 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 208000005069 pulmonary fibrosis Diseases 0.000 claims 1
- 125000004307 pyrazin-2-yl group Chemical group [H]C1=C([H])N=C(*)C([H])=N1 0.000 claims 1
- 230000000241 respiratory effect Effects 0.000 claims 1
- 206010039083 rhinitis Diseases 0.000 claims 1
- 230000035939 shock Effects 0.000 claims 1
- 201000009890 sinusitis Diseases 0.000 claims 1
- 208000011580 syndromic disease Diseases 0.000 claims 1
- 230000009885 systemic effect Effects 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D419/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
- C07D419/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
Claims (17)
1. Spoj formule (I):
[image]
,
naznačen time što:
R1 je vodik, C1-3alkil, CH2OH, CH2-O-CH3, CH2OCH2Ph, CH2CN, CN, halogen ili C(O)OCH3;
R2 je neovisno vodik, CN, CF3, halogen, SO2C1-3alkil, C1-3alkil ili C≡CH;
R3 je vodik, C1-2alkil, CF3 ili OH;
R4 je vodik, halogen ili C1-3alkil;
X je CR4 ili N;
A je (CH2)n-Het;
ili je A (CH2)n-(CRaRb)-(CH2)m-Het;
Ra je vodik ili C1-3alkil, gdje C1-3alkil može biti dodatno supstituiran s jednim ili više halogena;
Rb je C1-3alkil;
ili Ra i Rb, zajedno s atomom ugljika na kojeg su vezani, tvore C3-6cikloalkilnu skupinu;
ili se jedan od atoma ugljika u C3-6cikloalkilnoj skupini, koju tvore Ra i Rb, može zamijeniti kisikom kako bi tvorili oksetan, tetrahidrofurilna ili tetrahidropiranilna skupina;
ili se jedan od atoma ugljika u C3-6cikloalkilnoj skupini, koju tvore Ra i Rb, može zamijeniti dušikom kako bi tvorili pirolidinilnu ili piperidinilnu skupinu;
Het je:
[image]
gdje Het može biti supstituiran s jednim, dva ili tri supstituenta, koje se bira između: halogena, C1-5alkila, CN, CH2F, CHF2, CF3, C3-6cikloalkila, (CH2)n-O-C1-3alkila, (CH2)n-fenila, (CH2)n-piridila, pirimidinila, pirazinila, CH(CH3)-O-C1-3alkila, CH(OH)-C1-5alkil, C(CH3)2-R5, C(O)N(CH3)p, N(C1-3alkil)p, NH2, C(O)NH2, oksetana, oksetan-CH3, tetrahidrofurila, tetrahidropiranila, morfolinila ili pirazolila;
gdje fenilni, pirazolilni, te piridilni supstituent na Het može biti dodatno supstituiran s jednim ili dva supstituenta, koje se bira između: halogena, CN, OCH3, C1-3alkila ili CF3;
i C1-5alkilni i C3-6cikloalkilni supstituent na Het može biti dodatno supstituiran s CN ili OH;
R5 je CN, O-C1-4alkil, (CH2)m-OH, (CH2)p-O-C(O)-O-C1-5alkil ili O-(CH2)p-O-R6;
R6 je C1-4alkil ili P(O)2(CH3)2;
n je neovisno 0, 1 ili 2;
m je neovisno 0, 1 ili 2;
p je neovisno 1 ili 2; i
y je 1, 2 ili 3;
ili njegova farmaceutski prihvatljiva sol.
2. Spoj u skladu s patentnim zahtjevom 1, naznačen time što je:
R1 je vodik, C1-3alkil, CH2OH, CH2-O-CH3, CH2OCH2Ph, CH2CN, CN, halogen ili C(O)OCH3;
R2 je neovisno vodik, CN, CF3, halogen, SO2C1-3alkil, C1-3alkil ili C≡CH;
R3 je vodik, C1-2alkil, CF3 ili OH;
R4 je vodik, halogen ili C1-3alkil;
X je CR4 ili N;
A je (CH2)n-Het;
ili je A (CH2)n-(CRaRb)-(CH2)m-Het;
Ra je vodik ili C1-3alkil, gdje C1-3alkil može biti dodatno supstituiran s jednim ili više halogena;
Rb je C1-3alkil;
ili Ra i Rb, zajedno s atomom ugljika na kojeg su vezani, tvore C3-6cikloalkilnu skupinu;
ili se jedan od atoma ugljika u C3-6cikloalkilnoj skupini, koju tvore Ra i Rb, može zamijeniti kisikom kako bi tvorili oksetan, tetrahidrofurilna ili tetrahidropiranilna skupina;
ili se jedan od atoma ugljika u C3-6cikloalkilnoj skupini, koju tvore Ra i Rb, može zamijeniti dušikom kako bi tvorili pirolidinilnu ili piperidinilnu skupinu;
Het je
[image]
gdje Het može biti supstituiran s jednim, dva ili tri supstituenta, koje se bira između: halogena, C1-5alkila, CN, CH2F, CHF2, CF3, C3-6cikloalkila, (CH2)n-O-C1-3alkila, (CH2)n-fenila, (CH2)n-piridila, pirimidinila, pirazinila, CH(CH3)-O-C1-3alkila, C(CH3)2-OH, C(CH3)2-O-CH3, C(CH3)2-CN, C(CH3)2-CH2OH, C(CH3)2-CH2-O-C(O)-OC1-5alkila, C(O)N(CH3)p, N(C1-3alkil)p, NH2, C(O)NH2, oksetana, oksetan-CH3, tetrahidrofurila ili tetrahidropiranila;
gdje fenilni i piridilni supstituent na Het može biti dodatno supstituiran s jednim ili dva supstituenta, koje se bira između: halogena, CN, OCH3, C1-3alkila ili CF3;
i C1-5alkilni i C3-6cikloalkilni supstituent na Het može biti dodatno supstituiran s CN ili OH;
n je neovisno 0, 1 ili 2;
m je neovisno 0, 1 ili 2;
p je neovisno 1 ili 2;
y je 1, 2 ili 3;
ili njegova farmaceutski prihvatljiva sol.
3. Spoj u skladu s patentnim zahtjevom 1 ili patentnim zahtjevom 2, naznačen time što je:
R1 je vodik, C1-3alkil ili CH2OH;
R2 je CN;
R3 je vodik;
X je N;
A je (CH2)n-Het;
ili je A (CH2)n-(CRaRb)-(CH2)m-Het;
Ra je vodik ili C1-3alkil, gdje C1-3alkil može biti dodatno supstituiran s jednim ili više halogena;
Rb je C1-3alkil;
ili Ra i Rb, zajedno s atomom ugljika na kojeg su vezani, tvore C3-6cikloalkilnu skupinu;
ili se jedan od atoma ugljika u C3-6cikloalkilnoj skupini, koju tvore Ra i Rb, može zamijeniti kisikom kako bi tvorili oksetan, tetrahidrofurilna ili tetrahidropiranilna skupina;
ili se jedan od atoma ugljika u C3-6cikloalkilnoj skupini, koju tvore Ra i Rb, može zamijeniti dušikom kako bi tvorili pirolidinilnu ili piperidinilnu skupinu;
Het je
[image]
gdje Het može biti supstituiran s jednim, dva ili tri supstituenta, koje se bira između: halogena, C1-5alkila, CN, CH2F, CHF2, CF3, C3-6cikloalkila, (CH2)n-O-C1-3alkila, (CH2)n-fenila, (CH2)n-piridila, pirimidinila, pirazinila, CH(CH3)-O-C1-3alkila, C(CH3)2-OH, C(CH3)2-O-CH3, C(CH3)2-CN, C(CH3)2-CH2OH, C(CH3)2-CH2-O-C(O)-OC1-5alkila, C(O)N(CH3)p, N(C1-3alkil)p, NH2, C(O)NH2, oksetana, oksetan-CH3, tetrahidrofurila ili tetrahidropiranila;
gdje fenilni i piridilni supstituent na Het može biti dodatno supstituiran s jednim ili dva supstituenta, koje se bira između: halogena, CN, OCH3, C1-3alkila ili CF3;
i C1-5alkilni i C3-6cikloalkilni supstituent na Het može biti dodatno supstituiran s CN ili OH;
n je neovisno 0 ili 1;
m je neovisno 0 ili 1;
p je neovisno 1 ili 2; i
y je 1 ili 2;
ili njegova farmaceutski prihvatljiva sol.
4. Spoj u skladu s bilo kojim od patentnih zahtjeva 1-3, naznačen time što je:
R1 je vodik, C1-3alkil ili CH2OH;
R2 je CN;
R3 je vodik;
X je N;
A je (CH2)n-Het;
ili je A (CH2)n-(CRaRb)-(CH2)m-Het;
Ra je vodik ili C1-3alkil, gdje C1-3alkil može biti dodatno supstituiran s jednim ili više halogena;
Rb je C1-3alkil;
ili Ra i Rb, zajedno s atomom ugljika na kojeg su vezani, tvore C3-6cikloalkilnu skupinu;
ili se jedan od atoma ugljika u C3-6cikloalkilnoj skupini, koju tvore Ra i Rb, može zamijeniti kisikom kako bi tvorili oksetan, tetrahidrofurilna ili tetrahidropiranilna skupina;
ili se jedan od atoma ugljika u C3-6cikloalkilnoj skupini, koju tvore Ra i Rb, može zamijeniti dušikom kako bi tvorili pirolidinilnu ili piperidinilnu skupinu;
Het je
[image]
gdje Het može biti supstituiran s jednim, dva ili tri supstituenta, koje se bira između: halogena, C1-5alkila, CN, CH2F, CHF2, CF3, C3-6cikloalkila, (CH2)n-O-C1-3alkila, (CH2)n-fenila, (CH2)n-piridila, pirimidinila, pirazinila, CH(CH3)-OC1-3alkila, C(CH3)2-OH, C(CH3)2-O-CH3, C(CH3)2-CN, C(CH3)2-CH2OH, C(CH3)2-CH2-O-C(O)-O-C1-5alkil, C(O)N(CH3)p, N(C1-3alkil)p, NH2, C(O)NH2, oksetana, oksetan-CH3, tetrahidrofurila ili tetrahidropiranila;
gdje fenilni i piridilni supstituent na Het može biti dodatno supstituiran s jednim ili dva supstituenta, koje se bira između: halogena, CN, OCH3, C1-3alkila ili CF3;
i C1-5alkilni i C3-6cikloalkilni supstituent na Het može biti dodatno supstituiran s CN ili OH;
n je neovisno 0 ili 1;
m je neovisno 0 ili 1;
p je neovisno 1 ili 2; i
y je 1 ili 2;
ili njegova farmaceutski prihvatljiva sol.
5. Spoj u skladu s bilo kojim od patentnih zahtjeva 1-4, naznačen time što je:
R1 je vodik, C1-3alkil ili CH2OH;
R2 je CN;
R3 je vodik;
X je N;
A je (CH2)n-Het;
Het je
[image]
[image]
gdje Het može biti supstituiran s jednim, dva ili tri supstituenta, koje se bira između: halogena, C1-5alkila, CN, CH2F, CHF2, CF3, C3-6cikloalkila, (CH2)n-O-C1-3alkila, (CH2)n-fenila, (CH2)n-piridila, pirimidinila, pirazinila, CH(CH3)-OC1-3alkila, C(CH3)2-OH, C(CH3)2-O-CH3, C(CH3)2-CN, C(CH3)2-CH2OH, C(CH3)2-CH2-O-C(O)-O-C1-5alkil, C(O)N(CH3)p, N(C1-3alkil)p, NH2, C(O)NH2, oksetana, oksetan-CH3, tetrahidrofurila ili tetrahidropiranila;
gdje fenilni i piridilni supstituent na Het može biti dodatno supstituiran s jednim ili dva supstituenta, koje se bira između: halogena, CN, OCH3, C1-3alkila ili CF3;
i C1-5alkilni i C3-6cikloalkilni supstituent na Het može biti dodatno supstituiran s CN ili OH;
n je neovisno 0 ili 1;
p je neovisno 1 ili 2; i
y je 1 ili 2;
ili njegova farmaceutski prihvatljiva sol.
6. Spoj u skladu s bilo kojim od patentnih zahtjeva 1-5, naznačen time što je:
R1 je vodik, C1-3alkil ili CH2OH;
R2 je CN;
R3 je vodik;
X je N;
A je (CH2)n-Het;
Het je
[image]
gdje Het može biti supstituiran s jednim, dva ili tri supstituenta, koje se bira između: halogena, C1-5alkila, CN, CH2F, CHF2, CF3, C3-6cikloalkila, (CH2)n-O-C1-3alkila, (CH2)n-fenila, (CH2)n-piridila, pirimidinila, pirazinila, CH(CH3)-O-C1-3alkila, C(CH3)2-OH, C(CH3)2-O-CH3, C(CH3)2-CN, C(CH3)2-CH2OH, C(CH3)2-CH2-O-C(O)-OC1-5alkila, C(O)N(CH3)p, N(C1-3alkil)p, NH2, C(O)NH2, oksetana, oksetan-CH3, tetrahidrofurila ili tetrahidropiranila;
gdje fenilni i piridilni supstituent na Het može biti dodatno supstituiran s jednim ili dva supstituenta, koje se bira između: halogena, CN, OCH3, C1-3alkila ili CF3;
i C1-5alkilni i C3-6cikloalkilni supstituent na Het može biti dodatno supstituiran s CN ili OH;
n je 0;
p je neovisno 1 ili 2; i
y je 1 ili 2;
ili njegova farmaceutski prihvatljiva sol.
7. Spoj u skladu s patentnim zahtjevom 1, naznačen time što se bira između:
1-({(5S,7S)-3-[3-(1,1-dimetiletil)-5-izoksazolil]-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il}metil)-1H-benzimidazol-6-karbonitril;
1-(((5S,7S)-3-(3-(2-cijanopropan-2-il)izoksazol-5-il)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-({(5S,7S)-3-[5-(1,1-dimetiletil)-3-izoksazolil]-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il}metil)-1H-benzimidazol-6-karbonitril;
1-{[(5S,7S)-7-metil-2-okso-3-(2-piridinilmetil)-1-oksa-3-azaspiro[4.5]dek-7-il]metil}-1H-benzimidazol-6-karbonitril;
1-({(5S,7S)-3-[2-metil-2-(5-fenil-1,3,4-oksadiazol-2-il)propil]-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il}metil)-1H-benzimidazol-6-karbonitril;
1-({(5S,7S)-3-[2-(3-etil-1,2,4-oksadiazol-5-il)-2-metilpropil]-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il}metil)-1H-benzimidazol-6-karbonitril;
1-[((5S,7S)-3-{[3-metil-1-(2-pirimidinil)-3-pirolidinil]metil}-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il)metil]-1H-benzimidazol-6-karbonitril;
1-({(5S,7S)-7-metil-2-okso-3-[(1-fenil-1H-1,2,3-triazol-4-il)metil]-1-oksa-3-azaspiro[4.5]dek-7-il}metil)-1H-benzimidazol-6-karbonitril;
1-{[(5S,7S)-2-okso-3-({1-[5-(trifluormetil)-3-piridinil]-1H-1,2,3-triazol-4-il}metil)-1-oksa-3-azaspiro[4.5]dek-7-il]metil}-1H-benzimidazol-6-karbonitril;
1-({(5S,7S)-3-[4-klor-3-(1,1-dimetiletil)-5-izoksazolil]-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il}metil)-1H-benzimidazol-6-karbonitril;
1-({(5S,7S)-7-metil-2-okso-3-[5-(trifluormetil)-2-piridinil]-1-oksa-3-azaspiro[4.5]dek-7-il}metil)-1H-benzimidazol-6-karbonitril;
1-({(5S,7S)-3-[6-(etiloksi)-3-piridinil]-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il}metil)-1H-benzimidazol-6-karbonitril;
1-(((5S,7S)-3-(6-metoksipiridin-3-il)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-(5-etoksipirazin-2-il)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-(6-metoksi-4-metilpiridin-3-il)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-(1-etil-5-metil-1H-pirazol-4-il)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((7S)-3-(5-metoksipirazin-2-il)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-(6-klorpiridin-3-il)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-(6-(dimetilamino)piridin-3-il)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
tert-butil-(2-(5-((5S,7S)-7-((6-cijano-1H-benzo[d]imidazol-1-il)metil)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-3-il)izoksazol-3-il)-2-metilpropil)-karbonate;
1-(((5S,7S)-3-(3-(1-hidroksi-2-metilpropan-2-il)izoksazol-5-il)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-(4,6-dimetoksipiridin-3-il)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-(6-etoksi-4-metilpiridin-3-il)-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-(6-etoksi-4-metilpiridazin-3-il)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-7-metil-2-okso-3-(2-(trifluormetil)pirimidin-5-il)-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-7-metil-2-okso-3-(3-(trifluormetil)piridin-2-il)-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-({(5S,7S)-3-[(5-klor-1-benzotien-3-il)metil]-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il}metil)-1H-benzimidazol-6-karbonitril;
1-{[(5S,7S)-3-(2-{3-[1-(etiloksi)etil]-1,2,4-oksadiazol-5-il}-2-metilpropil)-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il]metil}-1H-benzimidazol-6-karbonitril;
1-{[(5S,7S)-7-metil-3-(5-metil-2-piridinil)-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il]metil}-1H-benzimidazol-6-karbonitril;
1-({(5S,7S)-7-metil-3-[3-(1-metiletil)-5-izoksazolil]-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il}metil)-1H-benzimidazol-6-karbonitril;
1-({(5S,7S)-7-metil-3-[3-(2-metilpropil)-5-izoksazolil]-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il}metil)-1H-benzimidazol-6-karbonitril;
1-{[(5S,7S)-3-(1-tert-butil-1H-pirazol-4-il)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il]metil}-1H-benzimidazol-6-karbonitril;
1-{[(5S,7S)-3-(3-etil-5-izoksazolil)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il]metil}-1H-benzimidazol-6-karbonitril;
1-{[(5S,7S)-3-(3-ciklopropil-5-izoksazolil)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il]metil}-1H-benzimidazol-6-karbonitril;
1-{[(5S,7S)-7-metil-2-okso-3-(3-fenil-5-izoksazolil)-1-oksa-3-azaspiro[4.5]dek-7-il]metil}-1H-benzimidazol-6-karbonitril;
1-({(5S,7S)-3-[3-(1,1-dimetiletil)-1-metil-1H-pirazol-5-il]-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il}metil)-1H-benzimidazol-6-karbonitril;
1-({(5S,7S)-7-metil-2-okso-3-[3-(trifluormetil)-5-izoksazolil]-1-oksa-3-azaspiro[4.5]dek-7-il}metil)-1H-benzimidazol-6-karbonitril;
1-({(5S,7S)-3-[3-(1-cijanociklopropil)-5-izoksazolil]-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il}metil)-1H-benzimidazol-6-karbonitril;
1-(((5S,7S)-3-(3-(2-fluorpropan-2-il)izoksazol-5-il)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-(3-ciklobutilizoksazol-5-il)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-(3-(tert-butil)-4-metilizoksazol-5-il)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-(4-(tert-butil)oksazol-2-il)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-(1-(tert-butil)-1H-pirazol-4-il)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-(3-(tert-butil)-4-fluorizoksazol-5-il)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-(3-(1,1-difluoretil)izoksazol-5-il)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-(3-(tert-butil)-4-metilizoksazol-5-il)-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-(3-(tert-butil)-4-fluorizoksazol-5-il)-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-(6-(tert-butil)piridazin-3-il)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-(5-(tert-butil)pirimidin-2-il)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-(2-(tert-butil)-2H-1,2,3-triazol-4-il)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-7-metil-3-(3-(1-metil-1H-pirazol-3-il)izoksazol-5-il)-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-(1-(tert-butil)-1H-1,2,3-triazol-4-il)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-(5-(tert-butil)pirazin-2-il)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-7-metil-2-okso-3-(5-(trifluormetil)pirimidin-2-il)-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-(6-(2-metoksipropan-2-il)piridin-3-il)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-7-metil-2-okso-3-(3-(prop-1-en-2-il)izoksazol-5-il)-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-(3,4-dimetilizoksazol-5-il)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-(3,4-dimetilizoksazol-5-il)-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-({3-[(5-klor-1-benzotien-3-il)metil]-2-okso-1-oksa-3-azaspiro[4.5]dek-7-ilmetil)-1H-indol-6-karbonitril;
1-({3-[(5-klor-1-benzotien-3-il)metil]-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il}metil)-2-(trifluormetil)-1H-benzimidazol-6-karbonitril;
1-({3-[(5-klor-1-benzotien-3-il)metil]-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il}metil)-1H-benzimidazol-6-karbonitril;
1-{[3-(1-benzotien-3-ilmetil)-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il]metil}-1H-benzimidazol-6-karbonitril;
1-({(5S,7S)-2-okso-3-[(2-fenil-1,3-tiazol-4-il)metil]-1-oksa-3-azaspiro[4.5]dek-7-il}metil)-1H-benzimidazol-6-karbonitril;
1-({(5S,7S)-2-okso-3-[(6-fenil-2-piridinil)metil]-1-oksa-3-azaspiro[4.5]dek-7-il}metil)-1H-benzimidazol-6-karbonitril;
1-[((5S,7S)-3-{2-metil-2-[3-(tetrahidro-2H-piran-4-il)-1,2,4-oksadiazol-5-il]propil}-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il)metil]-1H-benzimidazol-6-karbonitril;
1-({(5S,7S)-2-okso-3-[(4-fenil-1,3-tiazol-2-il)metil]-1-oksa-3-azaspiro[4.5]dek-7-il}metil)-1H-benzimidazol-6-karbonitril;
1-[((5S,7S)-3-{[3-(4-klorfenil)-5-izoksazolil]metil}-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il)metil]-1H-benzimidazol-6-karbonitril;
1-({(5S,7S)-2-okso-3-[(3-fenil-5-izoksazolil)metil]-1-oksa-3-azaspiro[4.5]dek-7-il}metil)-1H-benzimidazol-6-karbonitril;
1-({(5S,7S)-3-[(1-metil-5-fenil-1H-pirazol-3-il)metil]-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il}metil)-1H-benzimidazol-6-karbonitril;
1-{[(5S,7S)-3-({4-[3-metil-4-(metiloksi)fenil]-1,3-tiazol-2-il}metil)-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il]metil}-1H-benzimidazol-6-karbonitril;
1-({(5S,7S)-2-okso-3-[(3-fenil-1H-1,2,4-triazol-5-il)metil]-1-oksa-3-azaspiro[4.5]dek-7-il}metil)-1H-benzimidazol-6-karbonitril;
1-({(5S,7S)-2-okso-3-[(5-fenil-3-piridinil)metil]-1-oksa-3-azaspiro[4.5]dek-7-il}metil)-1H-benzimidazol-6-karbonitril-trifluoracetat;
4-klor-1-({(5S,7S)-3-[2-metil-2-(3-fenil-1,2,4-oksadiazol-5-il)propil]-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il}metil)-1H-benzimidazol-6-karbonitril;
1-({(5S,7S)-3-[2-metil-2-(3-metil-1,2,4-oksadiazol-5-il)propil]-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il}metil)-1H-benzimidazol-6-karbonitril;
1-({(5S,7S)-3-[2-metil-2-(3-fenil-1,2,4-oksadiazol-5-il)propil]-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il}metil)-1H-benzimidazol-6-karbonitril;
1-[((5S,7S)-3-{2-metil-2-[3-(1-metiletil)-1,2,4-oksadiazol-5-il]propil}-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il)metil]-1H-benzimidazol-6-karbonitril;
1-({(5S,7S)-3-[2-(3-ciklopentil-1,2,4-oksadiazol-5-il)-2-metilpropil]-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il}metil)-1H-benzimidazol-6-karbonitril;
1-[((5S,7S)-3-{2-metil-2-[3-(5-pirimidinil)-1,2,4-oksadiazol-5-il]propil}-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il)metil]-1H-benzimidazol-6-karbonitril;
1-[((5S,7S)-3-{2-[3-(1,1-dimetiletil)-1,2,4-oksadiazol-5-il]-2-metilpropil}-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il)metil]-1H-benzimidazol-6-karbonitril;
1-[((5S,7S)-3-{2-metil-2-[3-(trifluormetil)-1,2,4-oksadiazol-5-il]propil}-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il)metil]-1H-benzimidazol-6-karbonitril;
1-{[(5S,7S)-3-(2-metil-2-{3-[(metiloksi)metil]-1,2,4-oksadiazol-5-il}propil)-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il]metil}-1H-benzimidazol-6-karbonitril;
1-[((5S,7S)-3-{2-metil-2-[3-(2-metilpropil)-1,2,4-oksadiazol-5-il]propil}-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il)metil]-1H-benzimidazol-6-karbonitril;
1-({(5S,7S)-3-[2-metil-2-(3-{[(1-metiletil)oksi]metil}-1,2,4-oksadiazol-5-il)propil]-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il}metil)-1H-benzimidazol-6-karbonitril;
4-klor-1-[((5S,7S)-2-okso-3-{[4-(3-fenil-1,2,4-oksadiazol-5-il)tetrahidro-2H-piran-4-il]metil}-1-oksa-3-azaspiro[4.5]dek-7-il)metil]-1H-benzimidazol-6-karbonitril;
4-klor-1-[((5S,7S)-3-{[4-(3-ciklopentil-1,2,4-oksadiazol-5-il)tetrahidro-2H-piran-4-il]metil}-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il)metil]-1H-benzimidazol-6-karbonitril;
1-[((5S,7S)-2-okso-3-{[1-(2-piridinil)-3-pirolidinil]metil}-1-oksa-3-azaspiro[4.5]dek-7-il)metil]-1H-benzimidazol-6-karbonitril;
1-({(5S,7S)-2-okso-3-[(1-fenil-1H-1,2,3-triazol-4-il)metil]-1-oksa-3-azaspiro[4.5]dek-7-il}metil)-1H-benzimidazol-6-karbonitril;
1-[((5S,7S)-3-{[1-(4-cijanofenil)-1H-1,2,3-triazol-4-il]metil}-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il)metil]-1H-benzimidazol-6-karbonitril;
1-[((5S,7S)-3-{[1-(4-klorfenil)-1H-1,2,3-triazol-4-il]metil}-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il)metil]-1H-benzimidazol-6-karbonitril;
1-[((5S,7S)-3-{[1-(3-klorfenil)-1H-1,2,3-triazol-4-il]metil}-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il)metil]-1H-benzimidazol-6-karbonitril;
1-[((5S,7S)-3-{[1-(4-metilfenil)-1H-1,2,3-triazol-4-il]metil}-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il)metil]-1H-benzimidazol-6-karbonitril;
1-[((5S,7S)-3-{[1-(3-cijanofenil)-1H-1,2,3-triazol-4-il]metil}-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il)metil]-1H-benzimidazol-6-karbonitril;
1-{[(5S,7S)-2-okso-3-({1-[3-(trifluormetil)fenil]-1H-1,2,3-triazol-4-il}metil)-1-oksa-3-azaspiro[4.5]dek-7-il]metil}-1H-benzimidazol-6-karbonitril;
1-[((5S,7S)-3-{[1-(3-fluorfenil)-1H-1,2,3-triazol-4-il]metil}-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il)metil]-1H-benzimidazol-6-karbonitril;
1-{[(5S,7S)-3-({1-[3-(metiloksi)fenil]-1H-1,2,3-triazol-4-il}metil)-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il]metil}-1H-benzimidazol-6-karbonitril;
1-[((5S,7S)-3-{[1-(3-metilfenil)-1H-1,2,3-triazol-4-il]metil}-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il)metil]-1H-benzimidazol-6-karbonitril;
1-({(5S,7S)-3-[(1-cikloheksil-1H-1,2,3-triazol-4-il)metil]-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il}metil)-1H-benzimidazol-6-karbonitril;
1-{[(5S,7S)-3-({1-[4-cijano-3-(trifluormetil)fenil]-1H-1,2,3-triazol-4-il}metil)-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il]metil}-1H-benzimidazol-6-karbonitril;
1-[((5S,7S)-3-{[1-(3-klor-5-cijanofenil)-1H-1,2,3-triazol-4-il]metil}-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il)metil]-1H-benzimidazol-6-karbonitril;
1-{[(5S,7S)-2-okso-3-({1-[2-(trifluormetil)-4-piridinil]-1H-1,2,3-triazol-4-il}metil)-1-oksa-3-azaspiro[4.5]dek-7-il]metil}-1H-benzimidazol-6-karbonitril;
1-[((5S,7S)-3-{[1-(3,5-difluorfenil)-1H-1,2,3-triazol-4-il]metil}-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il)metil]-1H-benzimidazol-6-karbonitril;
1-{[(5S,7S)-2-okso-3-({1-[4-(trifluormetil)fenil]-1H-1,2,3-triazol-4-il}metil)-1-oksa-3-azaspiro[4.5]dek-7-il]metil}-1H-benzimidazol-6-karbonitril;
1-[((5S,7S)-3-{[1-(3-cijano-5-fluorfenil)-1H-1,2,3-triazol-4-il]metil}-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il)metil]-1H-benzimidazol-6-karbonitril;
1-[((5S,7S)-7-metil-3-{[1-(1-metiletil)-1H-1,2,3-triazol-4-il]metil}-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il)metil]-1H-benzimidazol-6-karbonitril;
1-({(5R,7S)-7-metil-2-okso-3-[(1-fenil-1H-1,2,3-triazol-4-il)metil]-1-oksa-3-azaspiro[4.5]dek-7-il}metil)-1H-benzimidazol-6-karbonitril;
1-[((5S,7S)-3-{[1-(5-klor-3-piridinil)-1H-1,2,3-triazol-4-il]metil}-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il)metil]-1H-benzimidazol-6-karbonitril;
1-(((5S,7S)-3-(4-klor-3-(2-cijanopropan-2-il)izoksazol-5-il)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-({(5S,7S)-3-[4-bromo-3-(1,1-dimetiletil)-5-izoksazolil]-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il}metil)-1H-benzimidazol-6-karbonitril;
1-({(5S,7S)-7-metil-3-[2-(metiloksi)-3-piridinil]-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il}metil)-1H-benzimidazol-6-karbonitril;
1-({(5S,7S)-3-[2,6-bis(metiloksi)-3-piridinil]-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il}metil)-1H-benzimidazol-6-karbonitril;
1-({(5S,7S)-3-[4-metil-6-(metiloksi)-3-piridinil]-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il}metil)-1H-benzimidazol-6-karbonitril;
1-(((7S)-3-(3,5-diklorpiridin-2-il)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-(2-etoksipirimidin-5-il)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-(5-klor-3-fluorpiridin-2-il)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-7-metil-2-okso-3-(5-(trifluormetil)pirazin-2-il)-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-(2-(tert-butil)pirimidin-5-il)-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-7-metil-3-(5-metilpirazin-2-il)-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-(6-etoksi-4-metilpiridin-3-il)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-(6-klor-4-metilpiridin-3-il)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-(6-klor-4-metilpiridin-3-il)-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-(5-klor-3-metilpiridin-2-il)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-(6-klor-4-metoksipiridin-3-il)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-(6-klor-4-metoksipiridin-3-il)-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-(4-metil-2-(trifluormetil)pirimidin-5-il)-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-(6-etoksi-4-metilpiridin-3-il)-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-5-fluor-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-(2-metoksi-6-metilpiridin-3-il)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-(3-metoksi-5-metilpiridin-2-il)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-(3-klor-5-metilpiridin-2-il)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-(3-etilpiridin-2-il)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-(3,5-dimetilpirazin-2-il)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-(3-metil-5-(trifluormetil)pirazin-2-il)-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-(6-metoksi-5-metilpiridin-3-il)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-(6-(2-cijanopropan-2-il)piridin-3-il)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-(2-(tert-butil)pirimidin-5-il)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-({(5S,7S)-7-metil-3-[5-(metiloksi)-2-piridinil]-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il}metil)-1H-benzimidazol-6-karbonitril;
1-({(5S,7S)-3-[6-(etiloksi)-3-piridazinil]-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il}metil)-1H-benzimidazol-6-karbonitril;
1-{[(5S,7S)-3-(3-klor-2-piridinil)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il]metil}-1H-benzimidazol-6-karbonitril;
1-({(5S,7S)-7-metil-3-[3-(metiloksi)-2-piridinil]-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il}metil)-1H-benzimidazol-6-karbonitril;
1-({(5S,7S)-7-metil-2-okso-3-[6-(trifluormetil)-3-piridinil]-1-oksa-3-azaspiro[4.5]dek-7-il}metil)-1H-benzimidazol-6-karbonitril;
1-(((7S)-7-metil-3-(6-metilpiridin-3-il)-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-({(5S,7S)-3-[4,6-bis(metiloksi)-3-piridinil]-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il}metil)-1H-benzimidazol-6-karbonitril;
1-({(5S,7S)-3-[6-(11-metiletil)-3-piridinil]-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il}metil)-1H-benzimidazol-6-karbonitril;
1-((7-(hidroksimetil)-3-(6-metoksi-4-metilpiridin-3-il)-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-7-metil-2-okso-3-(4-(trifluormetil)piridin-3-il)-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-(2-(dimetilamino)pirimidin-5-il)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-7-metil-3-(4-metilpiridin-3-il)-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-(5-(2-hidroksipropan-2-il)pirazin-2-il)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-(2-(2-hidroksipropan-2-il)pirimidin-5-il)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-(4-metoksipiridin-3-il)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-(5-(dimetilamino)pirazin-2-il)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-{[(5S,7S)-2-okso-3-(tieno[2,3-b]piridin-3-ilmetil)-1-oksa-3-azaspiro[4.5]dek-7-il]metil}-1H-benzimidazol-6-karbonitril;
1-{[trans-7-metil-2-okso-3-(tieno[2,3-b]piridin-3-ilmetil)-1-oksa-3-azaspiro[4.5]dek-7-il]metil}-1H-benzimidazol-6-karbonitril;
1-({(5S,7S)-3-[(3-bromotieno[2,3-b]piridin-2-il)metil]-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il}metil)-1H-benzimidazol-6-karbonitril;
1-{[(5S,7S)-3-(2-metil-2-{3-[1-(metiloksi)etil]-1,2,4-oksadiazol-5-il}propil)-2-okso-1-oksa-3-azaspiro[4.5]dek-7-il]metil}-1H-benzimidazol-6-karbonitril;
1-(((5S,7S)-3-((5-etoksipirazin-2-il)metil)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-((4-etoksipiridin-2-il)metil)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-((5-etoksipiridin-2-il)metil)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-((4-fluorpiridin-2-il)metil)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-((5-fluorpiridin-2-il)metil)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-7-metil-3-((4-(1-metil-1H-pirazol-4-il)piridin-2-il)metil)-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-7-metil-3-((6-(1-metil-1H-pirazol-4-il)piridin-2-il)metil)-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-(5-(2-metoksipropan-2-il)pirazin-2-il)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-(5-(2-(2-metoksietoksi)propan-2-il)pirazin-2-il)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
2-((2-(5-((5S,7S)-7-((6-cijano-1H-benzo[d]imidazol-1-il)metil)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-3-il)pirazin-2-il)propan-2-il)oksi)etil-dimetilfosfinat;
1-(((5S,7S)-3-(5′-fluor-4-metil-[2,2′-bipiridin]-5-il)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-7-metil-3-(4-metil-6-morfolinopiridin-3-il)-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-(5-(2-hidroksipropan-2-il)piridin-2-il)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-(5-(1-hidroksi-2-metilpropan-2-il)pirazin-2-il)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
1-(((5S,7S)-3-(6-ciklopropil-4-metoksipiridin-3-il)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril;
ili njihovih farmaceutski prihvatljivih soli.
8. Spoj u skladu s patentnim zahtjevom 1, naznačen time što je 1-(((5S,7S)-3-(5-etoksipirazin-2-il)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril,
[image]
,
ili njegova farmaceutski prihvatljiva sol.
9. Spoj u skladu s patentnim zahtjevom 1, naznačen time što je 1-(((5S,7S)-3-(5-(2-hidroksipropan-2-il)pirazin-2-il)-7-metil-2-okso-1-oksa-3-azaspiro[4.5]dekan-7-il)metil)-1H-benzo[d]imidazol-6-karbonitril,
[image]
,
ili njegova farmaceutski prihvatljiva sol.
10. Farmaceutski pripravak, naznačen time što sadrži spoj u skladu s bilo kojim od patentnih zahtjeva 1-9, kao i farmaceutski prihvatljivu podlogu ili pomoćnu tvar.
11. Spoj, namijenjen upotrebi u terapiji, naznačen time što spoj je spoj u skladu s bilo kojim od patentnih zahtjeva 1-9.
12. Spoj, namijenjen upotrebi u liječenju ili sprječavanju stanja, naznačen time što stanje se bira iz skupine koju čine ateroskleroza, poremećaji povezani s crijevnim edemom, postoperativni trbušni edem, lokalni i sistemni edem, retencija tekućina, sepsa, hipertenzija, upala, disfunkcije povezane s kostima i kongestivna srčana insuficijencija, plućni poremećaji, kronični opstruktivni plućni poremećaj, ozljeda pluća uzrokovana respiratorom, plućni edem uzrokovan velikom nadmorskom visinom, akutni sindrom respiratornog šoka, akutna ozljeda pluća, plućna fibroza, sinusitis/rinitis, astma, hiperaktivni mokraćni mjehur, bol, poremećaji motoričkih neurona, poremećaji genetički pojačane funkcije, kardiovaskularna bolest, disfunkcija bubrega, osteoartritis, Crohnova bolest, kolitis, proljev, nepravilnost rada crijeva (hiperreaktivnost/hiporeaktivnost), inkontinencija stolice, sindrom iritabilnih crijeva (IBS), konstipacija, bol i grčevi u crijevima, celijakija, nepodnošenje laktoze, te vjetrovi, gdje je spoj spoj u skladu s bilo kojim od patentnih zahtjeva 1-9.
13. Spoj, namijenjen upotrebi u skladu s patentnim zahtjevom 12, naznačen time što se spoj primjenjuje oralno.
14. Spoj, namijenjen upotrebi u skladu s patentnim zahtjevom 12, naznačen time što se spoj primjenjuje intravenski.
15. Spoj, namijenjen upotrebi u skladu s patentnim zahtjevom 12, naznačen time što se spoj primjenjuje inhalacijom.
16. Spoj, namijenjen upotrebi u skladu s patentnim zahtjevom 12, naznačen time što je bolest kongestivna srčana insuficijencija.
17. Spoj, namijenjen upotrebi u skladu s patentnim zahtjevom 12, naznačen time što je bolest akutna ozljeda pluća.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161498110P | 2011-06-17 | 2011-06-17 | |
PCT/US2012/042622 WO2013012500A1 (en) | 2011-06-17 | 2012-06-15 | Trpv4 antagonists |
EP12814591.9A EP2721016B1 (en) | 2011-06-17 | 2012-06-15 | Trpv4 antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20160539T1 true HRP20160539T1 (hr) | 2016-06-17 |
Family
ID=47558389
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HRP20160539TT HRP20160539T1 (hr) | 2011-06-17 | 2016-05-19 | Antagonisti trpv4 |
Country Status (38)
Country | Link |
---|---|
US (1) | US9187464B2 (hr) |
EP (2) | EP2721016B1 (hr) |
JP (1) | JP5969017B2 (hr) |
KR (1) | KR101870003B1 (hr) |
CN (1) | CN103732583B (hr) |
AR (1) | AR086958A1 (hr) |
AU (1) | AU2012284540B2 (hr) |
BR (1) | BR112013032391B1 (hr) |
CA (1) | CA2839743C (hr) |
CL (1) | CL2013003602A1 (hr) |
CO (1) | CO6821953A2 (hr) |
CR (1) | CR20130671A (hr) |
CY (1) | CY1117792T1 (hr) |
DK (1) | DK2721016T3 (hr) |
DO (1) | DOP2013000307A (hr) |
EA (1) | EA023616B1 (hr) |
ES (2) | ES2688733T3 (hr) |
HK (1) | HK1195068A1 (hr) |
HR (1) | HRP20160539T1 (hr) |
HU (1) | HUE029594T2 (hr) |
IL (1) | IL229872A (hr) |
JO (1) | JO3154B1 (hr) |
MA (1) | MA35184B1 (hr) |
ME (1) | ME02416B (hr) |
MX (1) | MX337440B (hr) |
MY (1) | MY173521A (hr) |
PE (1) | PE20141943A1 (hr) |
PL (1) | PL2721016T3 (hr) |
PT (1) | PT2721016E (hr) |
RS (1) | RS54858B1 (hr) |
SG (1) | SG195106A1 (hr) |
SI (1) | SI2721016T1 (hr) |
SM (1) | SMT201600150B (hr) |
TW (1) | TWI538912B (hr) |
UA (1) | UA113963C2 (hr) |
UY (1) | UY34138A (hr) |
WO (1) | WO2013012500A1 (hr) |
ZA (1) | ZA201308816B (hr) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2720546B1 (en) | 2011-06-17 | 2016-04-06 | Glaxosmithkline Intellectual Property (No. 2) Limited | Spiro-cyclic trpv4 antagonists |
WO2012174340A1 (en) * | 2011-06-17 | 2012-12-20 | Glaxosmithkline Llc | Trpv4 antagonists |
JPWO2013146754A1 (ja) | 2012-03-27 | 2015-12-14 | 塩野義製薬株式会社 | Trpv4阻害活性を有する芳香族複素5員環誘導体 |
WO2015046193A1 (ja) | 2013-09-25 | 2015-04-02 | 塩野義製薬株式会社 | Trpv4阻害活性を有する芳香族複素環式アミン誘導体 |
BR112018073700A2 (pt) * | 2016-05-19 | 2019-02-26 | Glaxosmithkline Intellectual Property (No. | antagonista trpv4 |
US10968209B2 (en) | 2016-05-19 | 2021-04-06 | Glaxosmithkline Intellectual Property (No.2) Limited | TRPV4 antagonist |
WO2018185701A1 (en) | 2017-04-06 | 2018-10-11 | Glaxosmithkline Intellectual Property (No.2) Limited | Trpv4 antagonists as antitussive agents |
PE20201184A1 (es) * | 2017-11-01 | 2020-11-03 | Bristol Myers Squibb Co | Compuestos espirociclicos como moduladores del receptor farnesoide x |
WO2021170811A1 (en) | 2020-02-27 | 2021-09-02 | Glaxosmithkline Intellectual Property (No.2) Limited | Method of treating eye disease using trpv4 antagonists |
CA3180132A1 (en) | 2020-04-30 | 2021-10-30 | Raqualia Pharma Inc. | Pyrimidin-4(3h)-one derivatives as trpv4 antagonists |
CN111704613B (zh) * | 2020-06-23 | 2021-07-06 | 中国人民解放军军事科学院军事医学研究院 | 咪唑类衍生物及其作为trpv4抑制剂的用途 |
WO2022014707A1 (ja) * | 2020-07-16 | 2022-01-20 | ラクオリア創薬株式会社 | 眼疾患の治療薬としてのtrpv4阻害薬 |
WO2024011214A1 (en) | 2022-07-08 | 2024-01-11 | Actio Biosciences, Inc. | Therapeutic compounds and methods |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999061436A1 (fr) * | 1998-05-26 | 1999-12-02 | Chugai Seiyaku Kabushiki Kaisha | Derives d'indole heterocycliques et derives de mono ou de di-azaindole |
JP2007534624A (ja) * | 2003-07-16 | 2007-11-29 | ニューロジェン・コーポレーション | ビアリールピペラジニル−ピリジン類縁体 |
CN101346375B (zh) * | 2005-11-23 | 2013-04-10 | 阿罗斯药物有限责任公司 | 调节门离子通道用组合物和方法 |
WO2007067756A2 (en) | 2005-12-08 | 2007-06-14 | Amphora Discovery Corporation | Certain chemical entities, compositions, and methods for modulating trpv1 |
AU2006327181A1 (en) * | 2005-12-22 | 2007-06-28 | Hydra Biosciences, Inc. | TRPA1 inhibitors for treating pain |
TW200819457A (en) * | 2006-08-30 | 2008-05-01 | Actelion Pharmaceuticals Ltd | Spiro antibiotic derivatives |
WO2008092891A1 (en) * | 2007-02-01 | 2008-08-07 | Glaxo Group Limited | 1-oxa-3-azaspiro(4.5)decan-2-one derivatives for the treatment of eating disorders |
GB0707934D0 (en) * | 2007-04-24 | 2007-05-30 | Glaxo Group Ltd | Chemical compounds |
MX2010001486A (es) * | 2007-08-09 | 2010-03-01 | Abbott Lab | Derivados de tetrahidropiridin carboxamida como antagonistas de trpvl. |
TW200944520A (en) * | 2008-01-29 | 2009-11-01 | Glaxo Group Ltd | Spiro compounds as NPY Y5 receptor antagonists |
EP2312947B1 (en) | 2008-07-25 | 2014-01-01 | GlaxoSmithKline LLC | Trpv4 antagonists |
JP2012006837A (ja) * | 2008-09-30 | 2012-01-12 | Mochida Pharmaceut Co Ltd | 2−インドールアクリルアミド類縁体 |
WO2012024183A1 (en) * | 2010-08-18 | 2012-02-23 | Merck Sharp & Dohme Corp. | Spiroxazolidinone compounds |
EP2720546B1 (en) * | 2011-06-17 | 2016-04-06 | Glaxosmithkline Intellectual Property (No. 2) Limited | Spiro-cyclic trpv4 antagonists |
WO2012174340A1 (en) | 2011-06-17 | 2012-12-20 | Glaxosmithkline Llc | Trpv4 antagonists |
-
2012
- 2012-06-14 JO JOP/2012/0159A patent/JO3154B1/ar active
- 2012-06-15 MY MYPI2013702447A patent/MY173521A/en unknown
- 2012-06-15 TW TW101121449A patent/TWI538912B/zh active
- 2012-06-15 JP JP2014516020A patent/JP5969017B2/ja active Active
- 2012-06-15 SG SG2013086483A patent/SG195106A1/en unknown
- 2012-06-15 DK DK12814591.9T patent/DK2721016T3/en active
- 2012-06-15 CN CN201280039690.0A patent/CN103732583B/zh active Active
- 2012-06-15 CA CA2839743A patent/CA2839743C/en active Active
- 2012-06-15 ES ES16162808T patent/ES2688733T3/es active Active
- 2012-06-15 PE PE2013002807A patent/PE20141943A1/es active IP Right Grant
- 2012-06-15 UY UY0001034138A patent/UY34138A/es not_active Application Discontinuation
- 2012-06-15 US US14/125,378 patent/US9187464B2/en active Active
- 2012-06-15 ME MEP-2016-120A patent/ME02416B/me unknown
- 2012-06-15 ES ES12814591T patent/ES2569193T3/es active Active
- 2012-06-15 AR ARP120102143A patent/AR086958A1/es active IP Right Grant
- 2012-06-15 PL PL12814591T patent/PL2721016T3/pl unknown
- 2012-06-15 BR BR112013032391-4A patent/BR112013032391B1/pt active IP Right Grant
- 2012-06-15 HU HUE12814591A patent/HUE029594T2/en unknown
- 2012-06-15 PT PT128145919T patent/PT2721016E/pt unknown
- 2012-06-15 SI SI201230564A patent/SI2721016T1/sl unknown
- 2012-06-15 WO PCT/US2012/042622 patent/WO2013012500A1/en active Application Filing
- 2012-06-15 EP EP12814591.9A patent/EP2721016B1/en active Active
- 2012-06-15 RS RS20160417A patent/RS54858B1/sr unknown
- 2012-06-15 UA UAA201400152A patent/UA113963C2/uk unknown
- 2012-06-15 EA EA201490037A patent/EA023616B1/ru not_active IP Right Cessation
- 2012-06-15 KR KR1020147000958A patent/KR101870003B1/ko not_active Application Discontinuation
- 2012-06-15 EP EP16162808.6A patent/EP3121177B1/en active Active
- 2012-06-15 AU AU2012284540A patent/AU2012284540B2/en active Active
- 2012-06-15 MX MX2013014898A patent/MX337440B/es active IP Right Grant
-
2013
- 2013-11-22 ZA ZA2013/08816A patent/ZA201308816B/en unknown
- 2013-12-09 IL IL229872A patent/IL229872A/en active IP Right Grant
- 2013-12-11 CO CO13290152A patent/CO6821953A2/es active IP Right Grant
- 2013-12-13 MA MA36564A patent/MA35184B1/fr unknown
- 2013-12-16 CL CL2013003602A patent/CL2013003602A1/es unknown
- 2013-12-17 CR CR20130671A patent/CR20130671A/es unknown
- 2013-12-17 DO DO2013000307A patent/DOP2013000307A/es unknown
-
2014
- 2014-08-20 HK HK14108527.9A patent/HK1195068A1/zh unknown
-
2016
- 2016-05-19 HR HRP20160539TT patent/HRP20160539T1/hr unknown
- 2016-05-31 SM SM201600150T patent/SMT201600150B/it unknown
- 2016-06-21 CY CY20161100556T patent/CY1117792T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20160539T1 (hr) | Antagonisti trpv4 | |
JP2014518214A5 (hr) | ||
HRP20171454T1 (hr) | Fuzionirani heterociklični spojevi kao modulatori ionskih kanala | |
JP2014525444A5 (hr) | ||
JP2019519484A5 (hr) | ||
KR101439823B1 (ko) | 골수증식성 질환 및 기타 증식성 질환의 치료에 유용한 키나제 억제제 | |
JP2018118992A5 (hr) | ||
HRP20200962T1 (hr) | Novi spojevi | |
HRP20191140T1 (hr) | Spojevi i pripravci kao inhibitori c-kit kinaze | |
HRP20180546T1 (hr) | Supstituirani benzilindazoli za uporabu kao inhibitori bub1 kinaze za liječenje hiperproliferativnih bolesti | |
JP2021501220A5 (hr) | ||
HRP20201746T1 (hr) | Aromatski derivati sulfonamida | |
JP2017530960A5 (hr) | ||
JP2013508404A5 (hr) | ||
JP2014531465A5 (hr) | ||
JP2017528519A5 (hr) | ||
JP2018527353A5 (hr) | ||
JP2011500806A5 (hr) | ||
RU2021133444A (ru) | Производные бензимидазола в качестве модуляторов ror-гамма | |
US9914736B2 (en) | TrKA kinase inhibitors, compositions and methods thereof | |
RU2018138050A (ru) | Производные тиазолопиридина как агонисты gpr119 | |
RU2016140338A (ru) | Азаспиро производные в качестве антагонистов trpm8 | |
RU2015129538A (ru) | Замещенные имидазопиридины в качестве ингибиторов hdm2 | |
JP2016500073A5 (hr) | ||
JP2014530238A5 (hr) |